SE101738C1
(sv)
|
1937-07-16 |
1941-06-10 |
Husqvarna Vapenfabriks Ab |
Sätt vid tillverkning av mangelvalsar
|
CH337989A
(fr)
|
1957-04-09 |
1959-04-30 |
Perrenoud Jean Pierre Dr |
Capsule
|
US3057344A
(en)
|
1957-05-21 |
1962-10-09 |
Abella Carlos Alberto |
Capsule for the study of the digestive tract and method of using the same
|
GB993734A
(en)
|
1963-01-04 |
1965-06-02 |
Nat Res Dev |
An improved sampling device for gastro-intestinal fluids
|
US3315660A
(en)
|
1963-08-08 |
1967-04-25 |
Carlos A Abella |
Capsule for insertion in the digestive track
|
US3485235A
(en)
|
1967-12-04 |
1969-12-23 |
Ronald Felson |
Capsule for the study and treatment of the digestive tract
|
CH557178A
(de)
*
|
1972-08-10 |
1974-12-31 |
Siemens Ag |
Geraet fuer die zufuehrung von medikamenten.
|
US4036214A
(en)
|
1975-04-14 |
1977-07-19 |
Louis Bucalo |
Fluid-collecting and microorganism-detecting devices
|
US4172446A
(en)
|
1974-12-20 |
1979-10-30 |
Louis Bucalo |
Apparatus for collecting body fluids
|
IL47062A
(en)
|
1975-04-10 |
1979-07-25 |
Yeda Res & Dev |
Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
|
US4239040A
(en)
|
1976-10-19 |
1980-12-16 |
Kabushiki Kaisha Daini Seikosha |
Capsule for medical use
|
JPS5349880A
(en)
|
1976-10-19 |
1978-05-06 |
Seiko Instr & Electronics |
Medical capsule
|
US4281645A
(en)
|
1977-06-28 |
1981-08-04 |
Duke University, Inc. |
Method and apparatus for monitoring metabolism in body organs
|
GB2039219B
(en)
|
1978-03-22 |
1982-10-06 |
Pawelec J |
Device for study of the alimentary canal
|
US4481952A
(en)
|
1978-03-22 |
1984-11-13 |
Jerzy Pawelec |
Device for the study of the alimentary canal
|
JPS5588732A
(en)
|
1978-12-26 |
1980-07-04 |
Olympus Optical Co |
Endoscope
|
US4665077A
(en)
|
1979-03-19 |
1987-05-12 |
The Upjohn Company |
Method for treating rejection of organ or skin grafts with 6-aryl pyrimidine compounds
|
DE2928477C3
(de)
|
1979-07-14 |
1982-04-15 |
Battelle-Institut E.V., 6000 Frankfurt |
Vorrichtung zur Freisetzung von Substanzen an definierten Orten des Verdauungstraktes
|
JPS57156736A
(en)
*
|
1981-03-23 |
1982-09-28 |
Olympus Optical Co |
Therapeutic capsule apparatus
|
JPS57163309A
(en)
|
1981-04-01 |
1982-10-07 |
Olympus Optical Co Ltd |
Capsule apparatus for medical use
|
US4522625A
(en)
*
|
1982-09-29 |
1985-06-11 |
Alza Corporation |
Drug dispenser comprising wall formed of semipermeable member and enteric member
|
AU2091583A
(en)
|
1982-11-03 |
1984-05-10 |
Gec-Xpelair Ltd. |
Actuator responsive to heat
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4573447A
(en)
|
1985-02-19 |
1986-03-04 |
Sunbelt America Corporation |
Chemical heater
|
JPS6226215A
(ja)
*
|
1985-05-10 |
1987-02-04 |
メルク エンド カムパニ− インコ−ポレ−テツド |
一定に制御した時間内胃中に保持できる薬剤移送装置
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
IL85746A
(en)
|
1988-03-15 |
1994-05-30 |
Yeda Res & Dev |
Preparations comprising t-lymphocyte cells treated with 8-methoxypsoralen or cell membranes separated therefrom for preventing or treating autoimmune diseases
|
FI891226A
(fi)
|
1988-04-28 |
1989-10-29 |
Univ Leland Stanford Junior |
Reseptordeterminanter i anti-t-celler foer behandling av autoimmunsjukdom.
|
US5075222A
(en)
|
1988-05-27 |
1991-12-24 |
Synergen, Inc. |
Interleukin-1 inhibitors
|
US4844076A
(en)
|
1988-08-26 |
1989-07-04 |
The Johns Hopkins University |
Ingestible size continuously transmitting temperature monitoring pill
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
WO1990008187A1
(en)
|
1989-01-19 |
1990-07-26 |
Dana Farber Cancer Institute |
Soluble two domain cd2 protein
|
ES2062519T5
(es)
|
1989-03-21 |
2003-07-16 |
Immune Response Corp Inc |
Vacunacion y metodos contra enfermedades originadas a partir de respuestas patogenicas mediante poblaciones especificas de linfocitos t.
|
IL94878A
(en)
|
1989-06-28 |
2003-01-12 |
Schering Corp |
Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
|
AU652540B2
(en)
|
1989-07-19 |
1994-09-01 |
Xoma Corporation |
T cell receptor peptides as therapeutics for autoimmune and malignant disease
|
AU630497B2
(en)
|
1989-09-05 |
1992-10-29 |
Immunex Corporation |
Tumor necrosis factor-alpha and -beta receptors
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5580756A
(en)
|
1990-03-26 |
1996-12-03 |
Bristol-Myers Squibb Co. |
B7Ig fusion protein
|
US5167626A
(en)
|
1990-10-02 |
1992-12-01 |
Glaxo Inc. |
Medical capsule device actuated by radio-frequency (RF) signal
|
US5170801A
(en)
*
|
1990-10-02 |
1992-12-15 |
Glaxo Inc. |
Medical capsule device actuated by radio-frequency (rf) signal
|
US5279607A
(en)
*
|
1991-05-30 |
1994-01-18 |
The State University Of New York |
Telemetry capsule and process
|
US5395366A
(en)
|
1991-05-30 |
1995-03-07 |
The State University Of New York |
Sampling capsule and process
|
GB9206422D0
(en)
|
1992-03-24 |
1992-05-06 |
Bolt Sarah L |
Antibody preparation
|
US7381803B1
(en)
|
1992-03-27 |
2008-06-03 |
Pdl Biopharma, Inc. |
Humanized antibodies against CD3
|
US5874082A
(en)
|
1992-07-09 |
1999-02-23 |
Chiron Corporation |
Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation
|
US5318557A
(en)
|
1992-07-13 |
1994-06-07 |
Elan Medical Technologies Limited |
Medication administering device
|
US5316015A
(en)
|
1992-07-30 |
1994-05-31 |
Sinaiko Robert J |
Externally controlled intestinal content sampler
|
US6180403B1
(en)
|
1999-10-28 |
2001-01-30 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression
|
EP0672144A1
(en)
|
1992-10-20 |
1995-09-20 |
Chiron Corporation |
Interleukin-6 receptor antagonists
|
CA2086631C
(en)
|
1992-12-22 |
1998-10-06 |
J. Gabriel Michael |
Oral administration of immunologically active biomolecules and other therapeutic proteins
|
EP0751962B1
(en)
|
1993-05-28 |
2006-08-02 |
The Scripps Research Institute |
Methods for inhibiting cd14 mediated cell activation
|
US5739103A
(en)
|
1993-11-12 |
1998-04-14 |
Dana-Farber Cancer Institute |
Chemokine N-terminal deletion mutations
|
JP3532570B2
(ja)
|
1994-01-13 |
2004-05-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
哺乳類単球化学誘引物質タンパク質レセプター
|
IL108352A
(en)
|
1994-01-17 |
2000-02-29 |
Given Imaging Ltd |
In vivo video camera system
|
US5705398A
(en)
|
1994-03-02 |
1998-01-06 |
The Scripps Research Institute |
Methods for identifying inhibitors of LPS-mediated LBP binding
|
US5857998A
(en)
|
1994-06-30 |
1999-01-12 |
Boston Scientific Corporation |
Stent and therapeutic delivery system
|
RU2218348C2
(ru)
|
1994-07-05 |
2003-12-10 |
Стено Рисерч Груп А/С |
Полипептид с il-10 подобными свойствами (варианты), конъюгат полипептида, фармацевтическая композиция, способ модуляции иммунного ответа у млекопитающего
|
KR100261941B1
(ko)
|
1994-07-13 |
2000-07-15 |
나가야마 오사무 |
사람의 인터루킨-8에 대한 재구성 사람항체
|
US5614191A
(en)
|
1995-03-15 |
1997-03-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
IL-13 receptor specific chimeric proteins and uses thereof
|
US6743594B1
(en)
|
1995-06-06 |
2004-06-01 |
Human Genome Sciences, Inc. |
Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
|
US7265083B2
(en)
|
1995-06-06 |
2007-09-04 |
The Regents Of The University Of Michigan |
Treatment of idiopathic pulmonary fibrosis using IP-10
|
US20030180290A1
(en)
|
1995-06-07 |
2003-09-25 |
Idec Pharmaceuticals Corporation |
Anti-CD80 antibody having ADCC activity for ADCC mediated killing of B cell lymphoma cells alone or in combination with other therapies
|
AU696393B2
(en)
|
1995-06-07 |
1998-09-10 |
Gen-Probe Incorporated |
Use of antisense oligonucleotides to IL-6 receptor mRNA to inhibit cellular proliferation
|
JP3604699B2
(ja)
|
1995-08-17 |
2004-12-22 |
プロテイン デザイン ラブス, インコーポレイティド |
多外傷後の多発性臓器不全の防止のための及び体外血液循環後の急性臓器損傷の防止のための抗−セレクチン抗体
|
AU718899C
(en)
|
1995-10-23 |
2004-01-29 |
Amrad Operations Pty. Limited |
A novel haemopoietin receptor and genetic sequences encoding same
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
ZA9610374B
(en)
|
1995-12-11 |
1997-06-23 |
Elan Med Tech |
Cartridge-based drug delivery device
|
WO1997024325A1
(en)
|
1995-12-28 |
1997-07-10 |
Takeda Chemical Industries, Ltd. |
DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS
|
AU4385696A
(en)
|
1996-01-18 |
1997-08-11 |
Christian Gronhoj Larsen |
Synthetic il-10 analogues
|
CN103275221B
(zh)
|
1996-02-09 |
2016-08-17 |
艾伯维生物技术有限公司 |
结合人TNFα的人抗体
|
SE9600820D0
(sv)
|
1996-03-01 |
1996-03-01 |
Pharmacia Ab |
Antibodies and their use
|
WO1997039772A1
(fr)
|
1996-04-19 |
1997-10-30 |
Chugai Seiyaku Kabushiki Kaisha |
Remede contre l'arthrite rhumatoide contenant un anticorps anti-il-8 comme principe actif
|
EP0914319B1
(en)
|
1996-05-20 |
2001-11-21 |
Teijin Limited |
Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
|
US5738110A
(en)
|
1996-05-29 |
1998-04-14 |
Beal; Charles B. |
Device for the diagnosis of certain gastrointestinal pathogens
|
CA2261633A1
(en)
|
1996-07-29 |
1998-02-05 |
Banyu Pharmaceutical Co., Ltd. |
Chemokine receptor antagonists
|
WO1998006751A1
(en)
|
1996-08-16 |
1998-02-19 |
Research Corporation Technologies, Inc. |
Mcp-3, rantes and mip-1alpha receptor antagonists
|
WO1998009642A2
(en)
|
1996-09-06 |
1998-03-12 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Therapeutic chemokine antagonists
|
WO1998011218A1
(en)
|
1996-09-10 |
1998-03-19 |
Theodor-Kocher Institute |
Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
|
US6140064A
(en)
|
1996-09-10 |
2000-10-31 |
Theodor-Kocher Institute |
Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3
|
US6528625B1
(en)
|
1996-10-28 |
2003-03-04 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR5 antibodies and kits comprising same
|
US5919792A
(en)
|
1996-10-30 |
1999-07-06 |
Merck & Co., Inc. |
Integrin antagonists
|
US5971942A
(en)
|
1996-12-03 |
1999-10-26 |
Gu; Howard H. |
Intestinal fluid sampler
|
AU5604998A
(en)
|
1996-12-13 |
1998-07-03 |
Merck & Co., Inc. |
Spiro-substituted azacycles as modulators of chemokine receptor activity
|
WO1998025617A1
(en)
|
1996-12-13 |
1998-06-18 |
Merck & Co., Inc. |
Substituted aryl piperazines as modulators of chemokine receptor activity
|
AU5803398A
(en)
|
1996-12-13 |
1998-07-03 |
Merck & Co., Inc. |
Spiro-substituted azacycles as modulators of chemokine receptor activity
|
AU5812498A
(en)
|
1996-12-20 |
1998-07-17 |
Merck & Co., Inc. |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
AU6133098A
(en)
|
1997-01-21 |
1998-08-07 |
Merck & Co., Inc. |
3,3-disubstituted piperidines as modulators of chemokine receptor activity
|
BR9807858A
(pt)
|
1997-02-26 |
2000-02-22 |
Pfizer |
Derivados de amida do ácido heteroaril-hexanóico, suas preparaçÊes e seus usos como inibidores seletios de mip-1.alfa ligando aos seus receptores ccr1
|
US20020018783A1
(en)
|
1997-03-20 |
2002-02-14 |
Michel Sadelain |
Fusion proteins of a single chain antibody and cd28 and uses thereof
|
WO1998043962A1
(en)
|
1997-03-28 |
1998-10-08 |
Du Pont Pharmaceuticals Company |
Heterocyclic integrin inhibitor prodrugs
|
DE19722888A1
(de)
|
1997-05-28 |
1998-12-03 |
Thomas Prof Dr Huenig |
Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten
|
US5951538A
(en)
|
1997-08-07 |
1999-09-14 |
Ceramatec, Inc. |
Gas generating device for delivering beneficial agents to a body cavity
|
GB9716657D0
(en)
|
1997-08-07 |
1997-10-15 |
Zeneca Ltd |
Chemical compounds
|
US7704944B2
(en)
|
1997-08-14 |
2010-04-27 |
Yeda Research And Development Company Ltd. |
Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
|
AU737735B2
(en)
|
1997-08-28 |
2001-08-30 |
Novartis Ag |
Lymphocyte function antigen-1 antagonists
|
US6046319A
(en)
|
1997-10-22 |
2000-04-04 |
University Technologies International, Inc. |
Antisense oligodeoxynucleotides regulating expression of TNF-α
|
ID24942A
(id)
|
1997-11-04 |
2000-08-31 |
Pfizer Prod Inc |
Senyawa terapi aktif yang berdasarkan penggantian bioisoster katekol dengan indazole pada inhibitor pde4
|
DE19801573A1
(de)
|
1998-01-19 |
1999-07-22 |
Suchatzki Bernd Ulrich Dr |
Sammler für lokale Probeflüssigkeiten und Verwendung eines solchen Sammlers im menschlichen oder tierischen Verdauugssystem
|
US7005504B2
(en)
|
1998-01-22 |
2006-02-28 |
Genentech, Inc. |
Antibody fragment-peg conjugates
|
GB9803228D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
CA2224551A1
(en)
|
1998-02-25 |
1999-08-25 |
Alex Hongsheng Chang |
A quick in situ diagnostic method for detecting alimentary diseases
|
US20040186071A1
(en)
|
1998-04-13 |
2004-09-23 |
Bennett C. Frank |
Antisense modulation of CD40 expression
|
US6197584B1
(en)
|
1998-05-01 |
2001-03-06 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of CD40 expression
|
US6369039B1
(en)
|
1998-06-30 |
2002-04-09 |
Scimed Life Sytems, Inc. |
High efficiency local drug delivery
|
US6727349B1
(en)
|
1998-07-23 |
2004-04-27 |
Millennium Pharmaceuticals, Inc. |
Recombinant anti-CCR2 antibodies and methods of use therefor
|
US6696550B2
(en)
|
1998-07-23 |
2004-02-24 |
Millennium Pharmaceuticals, Inc. |
Humanized anti-CCR2 antibodies and methods of use therefor
|
US6312689B1
(en)
|
1998-07-23 |
2001-11-06 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR2 antibodies and methods of use therefor
|
ATE414536T1
(de)
|
1998-08-11 |
2008-12-15 |
Biogen Idec Inc |
Kombinationstherapien gegen b-zell-lymphome beinhaltend die verabreichung von anti-cd20- antikörpern
|
US6228642B1
(en)
|
1998-10-05 |
2001-05-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression
|
US6080580A
(en)
|
1998-10-05 |
2000-06-27 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression
|
IL126727A
(en)
|
1998-10-22 |
2006-12-31 |
Given Imaging Ltd |
A method of bringing a device to the goal
|
JP2002529429A
(ja)
|
1998-11-09 |
2002-09-10 |
アイデック・ファーマシューティカルズ・コーポレイション |
Bmtまたはpbsc移植を受ける患者のキメラ化抗cd20抗体による治療。
|
EP1949910A1
(en)
|
1998-11-09 |
2008-07-30 |
Biogen Idec, Inc. |
Treatment of chronic lymphocytic leukemia (CLL) using chimeric anti-CD20 antibody.
|
GB9825632D0
(en)
|
1998-11-23 |
1999-01-13 |
Novartis Ag |
Organic compounds
|
US20080015348A1
(en)
|
1998-12-16 |
2008-01-17 |
Progenics Pharmaceuticals, Inc. |
Nucleic acids encoding polypeptides of anti-CCR5 antibodies
|
US20040228869A1
(en)
|
1998-12-16 |
2004-11-18 |
Progenics Pharmaceuticals, Inc. |
Synergistic inhibition of HIV-1 fusion and attachment, compositions and antibodies thereto
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US20020142000A1
(en)
|
1999-01-15 |
2002-10-03 |
Digan Mary Ellen |
Anti-CD3 immunotoxins and therapeutic uses therefor
|
JP2002535314A
(ja)
|
1999-01-22 |
2002-10-22 |
エラン ファーマシューティカルズ,インコーポレイテッド |
Vla−4により媒介される白血球接着を阻害する化合物
|
GB9902459D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902461D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB9902452D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
US6329159B1
(en)
|
1999-03-11 |
2001-12-11 |
Millennium Pharmaceuticals, Inc. |
Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
|
PT1176960E
(pt)
|
1999-05-04 |
2005-02-28 |
Altana Pharma Ag |
Combinacao sinergica compreendendo roflumilast e um inibidor de pde-3
|
WO2000073457A1
(en)
|
1999-05-27 |
2000-12-07 |
Schering-Corporation |
Mammalian interleukin-10 homologs: il-d110 and il-d210
|
ITMI991299A1
(it)
|
1999-06-11 |
2000-12-11 |
Consiglio Nazionale Ricerche |
Uso di anticorpi contro antigeni di superficie per il trattamento della malattia trapianto contro ospite
|
IL130486A
(en)
|
1999-06-15 |
2005-08-31 |
Given Imaging Ltd |
Optical system
|
US7813789B2
(en)
|
1999-06-15 |
2010-10-12 |
Given Imaging Ltd. |
In-vivo imaging device, optical system and method
|
US8557244B1
(en)
|
1999-08-11 |
2013-10-15 |
Biogen Idec Inc. |
Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
|
DE19939653A1
(de)
|
1999-08-13 |
2001-02-22 |
Thomas Huenig |
Verwendung CD28 spezifischer monoklonaler Antikörper zur Herstellung einer pharmazeutischen Zusammensetzung
|
US7033781B1
(en)
|
1999-09-29 |
2006-04-25 |
Diversa Corporation |
Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
|
US20070111259A1
(en)
|
1999-10-02 |
2007-05-17 |
Medarex, Inc. |
Human antibodies
|
US6576429B1
(en)
|
1999-10-26 |
2003-06-10 |
Alimenta Diagnostics Ab |
Apparatus for intestinal sampling and use thereof
|
NZ518002A
(en)
|
1999-10-29 |
2004-01-30 |
Smithkline Beecham Corp |
Method for administering a phosphodiesterase 4 inhibitor
|
WO2001034194A1
(en)
|
1999-11-08 |
2001-05-17 |
Idec Pharmaceuticals Corporation |
Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy
|
US6344027B1
(en)
|
1999-12-08 |
2002-02-05 |
Scimed Life Systems, Inc. |
Needle-less injection apparatus and method
|
US20020006403A1
(en)
|
1999-12-14 |
2002-01-17 |
Xue-Zhong Yu |
CD28-specific antibody compositions for use in methods of immunosuppression
|
GB9930000D0
(en)
|
1999-12-21 |
2000-02-09 |
Phaeton Research Ltd |
An ingestible device
|
GB9930001D0
(en)
|
1999-12-21 |
2000-02-09 |
Phaeton Research Ltd |
An ingestible device
|
ATE464892T1
(de)
|
2000-02-03 |
2010-05-15 |
Eisai R&D Man Co Ltd |
Inhibitoren der integrinexpression
|
DE60127656T2
(de)
|
2000-02-25 |
2007-12-20 |
Immunex Corp., Seattle |
Integrin antagonisten
|
WO2001068586A2
(en)
|
2000-03-14 |
2001-09-20 |
Novartis Ag |
α4β1 AND α4β7 INTEGRIN INHIBITORS
|
GB0006398D0
(en)
|
2000-03-16 |
2000-05-03 |
Novartis Ag |
Organic compounds
|
EP2258689A1
(en)
|
2000-03-16 |
2010-12-08 |
Biolipox AB |
Benzylated PDE4 inhibitors
|
GB0007911D0
(en)
|
2000-03-30 |
2000-05-17 |
Novartis Ag |
Organic compounds
|
CN1981868A
(zh)
|
2000-03-31 |
2007-06-20 |
拜奥根Idec公司 |
抗细胞因子抗体或拮抗剂与抗-cd20在b细胞淋巴瘤治疗中的联合应用
|
US20040092712A1
(en)
|
2000-03-31 |
2004-05-13 |
Shoji Furusako |
Tlr/cd14 binding inhibitor
|
WO2001079300A1
(en)
|
2000-04-12 |
2001-10-25 |
Genetics Institute, Llc. |
Surface-bound antigen binding portions of antibodies that bind to ctla-4 and cd28 and uses therefor
|
US20070160574A1
(en)
|
2000-04-12 |
2007-07-12 |
Ahmed Merzouk |
Design of CXC chemokine analogs for the treatment of human diseases
|
US20070116669A1
(en)
|
2002-09-13 |
2007-05-24 |
Chemokine Therapeutics Corporation |
Interferon-inducible protein-10 (IP-10 or CXCL10) chemokine analogs for the treatment of human diseases
|
US20020018776A1
(en)
|
2000-04-14 |
2002-02-14 |
Millennium Pharmaceuticals, Inc. |
Method of treating graft rejection using inhibitors of CXCR3 function
|
WO2001078707A1
(en)
|
2000-04-14 |
2001-10-25 |
Millennium Pharmaceuticals, Inc. |
Treating graft rejection with ccr5 inhibitors
|
US20020042370A1
(en)
|
2000-04-14 |
2002-04-11 |
Millennium Pharmaceuticals, Inc. |
Method of treating graft rejection using inhibitors of CCR2 function
|
PT1294874E
(pt)
|
2000-06-09 |
2006-09-29 |
Biogen Idec Inc |
Variantes de cd154 e as suas utilizacoes
|
EP2052742A1
(en)
|
2000-06-20 |
2009-04-29 |
Biogen Idec Inc. |
Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combination
|
GB0016138D0
(en)
|
2000-06-30 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
US6794506B2
(en)
|
2000-07-21 |
2004-09-21 |
Elan Pharmaceuticals, Inc. |
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
DE10040105A1
(de)
|
2000-08-17 |
2002-02-28 |
Merck Patent Gmbh |
Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften
|
US20020099310A1
(en)
|
2001-01-22 |
2002-07-25 |
V-Target Ltd. |
Gastrointestinal-tract sensor
|
GB0020685D0
(en)
|
2000-08-22 |
2000-10-11 |
Novartis Ag |
Organic compounds
|
NZ524980A
(en)
|
2000-09-01 |
2005-10-28 |
Biogen Idec Inc |
Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications
|
EP2295450B1
(en)
|
2000-09-29 |
2015-01-28 |
Merck Sharp & Dohme Corp. |
Pegylated interleukin-10
|
AU2001296507A1
(en)
|
2000-10-02 |
2002-04-15 |
Chiron Corporation |
Human anti-cd40 antibodies
|
WO2002045749A2
(en)
|
2000-11-02 |
2002-06-13 |
Research Foundation Of City University Of New York |
Methods for stimulating nervous system regeneration and repair by inhibition phosphodiesterase type 4
|
WO2002042333A1
(fr)
|
2000-11-22 |
2002-05-30 |
Mochida Pharmaceutical Co., Ltd. |
Anticorps monoclonal anti-cd14 exerçant un effet d'inhibition de la fixation cd14/tlr
|
AU2001297717B2
(en)
|
2000-12-11 |
2006-02-23 |
Amgen Inc. |
CXCR3 antagonists
|
DK1345969T3
(da)
|
2000-12-26 |
2010-11-29 |
Inst Nat Sante Rech Med |
Anti-CD28-antistof
|
US7553276B2
(en)
|
2001-01-16 |
2009-06-30 |
Given Imaging Ltd. |
Method and device for imaging body lumens
|
EP1359845B1
(en)
|
2001-01-22 |
2012-11-14 |
Spectrum Dynamics LLC |
Ingestible device
|
US20070065436A1
(en)
|
2001-01-31 |
2007-03-22 |
Biogen Idec Inc. |
Anti-cd80 antibody having adcc activity for adcc mediated killing of b cell lymphoma cells alone or in combination with other therapies
|
US6962926B2
(en)
|
2001-01-31 |
2005-11-08 |
Telik, Inc. |
Antagonist of MCP-1 function, and compositions and methods of use thereof
|
US20030204085A1
(en)
|
2001-02-02 |
2003-10-30 |
Taveras Arthur G. |
3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
|
BR0206968A
(pt)
|
2001-02-02 |
2004-03-09 |
Schering Corp |
Ciclobuteno-1,2-dionas 3,4-dissubstituìdas como antagonistas receptores de quimiocina cxc
|
CA2437814C
(en)
|
2001-02-12 |
2008-05-13 |
Medarex, Inc. |
Human monoclonal antibodies to fc alpha receptor (cd89)
|
WO2002066059A2
(en)
|
2001-02-16 |
2002-08-29 |
Genetics Institute, Llc |
Agents that specifically block cd28-mediated signaling and uses therefor
|
US20080095774A1
(en)
|
2001-02-16 |
2008-04-24 |
Wyeth |
Agents and Methods for Specifically Blocking CD28-Mediated Signaling
|
TWI245761B
(en)
|
2001-03-01 |
2005-12-21 |
Telik Inc |
Antagonists of MCP-1 function and methods of use thereof
|
US7201895B2
(en)
|
2001-03-01 |
2007-04-10 |
University Of Saskatchewan Technologies Inc. |
High-affinity antagonists of ELR-CXC chemokines
|
US20030003440A1
(en)
|
2001-03-14 |
2003-01-02 |
Lucia Lopalco |
Novel CCR5 epitope and antibodies against it
|
ES2365696T3
(es)
|
2001-03-14 |
2011-10-10 |
Given Imaging Ltd. |
Método y sistema para detectar anormalidades colorimétricas.
|
EP1243524A3
(en)
|
2001-03-16 |
2004-04-07 |
Pfizer Products Inc. |
Pharmaceutical kit for oxygen-sensitive drugs
|
DE10114178A1
(de)
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
US20020150882A1
(en)
|
2001-04-16 |
2002-10-17 |
Andrew Devitt |
Antibody specific to CD14 and uses thereof
|
EP2011802A3
(en)
|
2001-04-27 |
2009-04-15 |
Kyowa Hakko Kirin Co., Ltd. |
Anti-CD40 monoclonal antibody
|
US6861504B2
(en)
|
2001-05-03 |
2005-03-01 |
Cbr, Inc. |
Compounds and methods for the modulation of CD154
|
EP1387634B1
(en)
|
2001-05-17 |
2006-05-03 |
Färgklämman AB |
Sampling device and method for obtaining samples of internal body substances and method for producing a sampling device
|
US20050227935A1
(en)
|
2001-05-18 |
2005-10-13 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TNF and TNF receptor gene expression using short interfering nucleic acid (siNA)
|
US20030211105A1
(en)
|
2001-05-18 |
2003-11-13 |
Murphy William J |
Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity
|
US6794379B2
(en)
|
2001-06-06 |
2004-09-21 |
Tularik Inc. |
CXCR3 antagonists
|
WO2002102224A2
(en)
|
2001-06-18 |
2002-12-27 |
Given Imaging Ltd. |
In vivo sensing device with a circuit board having rigid sections and flexible sections
|
US7160258B2
(en)
|
2001-06-26 |
2007-01-09 |
Entrack, Inc. |
Capsule and method for treating or diagnosing the intestinal tract
|
GB0118266D0
(en)
|
2001-07-26 |
2001-09-19 |
Powderject Res Ltd |
Silencing device and method for needleless syringe
|
US7347817B2
(en)
|
2001-08-02 |
2008-03-25 |
Given Imaging Ltd. |
Polarized in vivo imaging device, system and method
|
EP1285922A1
(en)
|
2001-08-13 |
2003-02-26 |
Warner-Lambert Company |
1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
|
US7615234B2
(en)
|
2001-09-11 |
2009-11-10 |
Glide Pharmaceutical Technologies Limited |
Drug delivery technology
|
DK1429807T3
(da)
|
2001-09-19 |
2007-06-18 |
Altana Pharma Ag |
Kombination af et NSAID og en PDE4-inhibitor
|
MXPA04003439A
(es)
|
2001-10-12 |
2004-07-08 |
Schering Corp |
Compuestos de maleimida 3,4 disustituidos como antagonistas de receptor de quimiocina cxc.
|
US20040116675A1
(en)
|
2001-12-14 |
2004-06-17 |
Tso J. Jun |
Silenced anti-cd28 antibodies and use thereof
|
US7393934B2
(en)
|
2001-12-21 |
2008-07-01 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor (CCR5) HDGNR10
|
US20040093621A1
(en)
|
2001-12-25 |
2004-05-13 |
Kyowa Hakko Kogyo Co., Ltd |
Antibody composition which specifically binds to CD20
|
US6878709B2
(en)
|
2002-01-04 |
2005-04-12 |
Schering Corporation |
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
|
DE10204789A1
(de)
|
2002-02-06 |
2003-08-14 |
Merck Patent Gmbh |
Inhibitoren des Integrins alpha¶v¶beta6
|
CA2476166C
(en)
|
2002-02-14 |
2011-11-15 |
Immunomedics, Inc. |
Anti-cd20 antibodies and fusion proteins thereof and methods of use
|
MY140561A
(en)
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
US7122185B2
(en)
|
2002-02-22 |
2006-10-17 |
Progenics Pharmaceuticals, Inc. |
Anti-CCR5 antibody
|
CA2373854A1
(en)
|
2002-02-28 |
2003-08-28 |
Alain Moreau |
Methods of diagnosing and counteracting adolescent idiopathic scoliosis
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
US20030216551A1
(en)
|
2002-03-08 |
2003-11-20 |
Diabetogen Biosciences Inc. |
Fully human anti-CD3 monoclonal antibodies
|
DE10212108A1
(de)
|
2002-03-13 |
2003-10-02 |
Tegenero Ag |
Verwendung einer an CD28 bindenden Wirksubstanz zur Herstellung einer pharmazeutischen Zusammensetzung
|
WO2003100033A2
(en)
|
2002-03-13 |
2003-12-04 |
Biogen Idec Ma Inc. |
ANTI-αvβ6 ANTIBODIES
|
US20030180292A1
(en)
|
2002-03-14 |
2003-09-25 |
Idec Pharmaceuticals |
Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy
|
EP1576013A4
(en)
|
2002-03-22 |
2008-08-13 |
Amrad Operations Pty Ltd |
MONOCLONAL ANTIBODY AGAINST THE INTERLEUKIN-13 RECEPTOR ALPHA 1 (IL-13RA1)
|
US7797033B2
(en)
|
2002-04-08 |
2010-09-14 |
Smart Pill Corporation |
Method of using, and determining location of, an ingestible capsule
|
BR0309238A
(pt)
|
2002-04-10 |
2005-02-15 |
Applied Research Systems |
Antagonistas de proteìnas mcp
|
US7662094B2
(en)
|
2002-05-14 |
2010-02-16 |
Given Imaging Ltd. |
Optical head assembly with dome, and device for use thereof
|
US20040254455A1
(en)
|
2002-05-15 |
2004-12-16 |
Iddan Gavriel J. |
Magneic switch for use in a system that includes an in-vivo device, and method of use thereof
|
US20100129363A1
(en)
|
2002-05-17 |
2010-05-27 |
Zeldis Jerome B |
Methods and compositions using pde4 inhibitors for the treatment and management of cancers
|
ATE359297T1
(de)
|
2002-06-12 |
2007-05-15 |
Applied Research Systems |
Antagonisten für cxcr3-bindende cxc-chemokine
|
US7153968B2
(en)
|
2002-06-25 |
2006-12-26 |
Merck Frosst Canada, Ltd. |
8-(biaryl)quinoline PDE4 inhibitors
|
US20050180972A1
(en)
|
2002-07-31 |
2005-08-18 |
Wahl Alan F. |
Anti-CD20 antibody-drug conjugates for the treatment of cancer and immune disorders
|
AU2003249551A1
(en)
|
2002-08-13 |
2004-02-25 |
Given Imaging Ltd. |
System for in vivo sampling and analysis
|
RS20050834A
(en)
|
2002-08-19 |
2007-12-31 |
Abgenix Inc., |
Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof
|
EP1400534B1
(en)
|
2002-09-10 |
2015-10-28 |
Affimed GmbH |
Human CD3-specific antibody with immunosuppressive properties
|
ATE469969T1
(de)
|
2002-09-12 |
2010-06-15 |
Chemo Sero Therapeut Res Inst |
Menschlicher anti-mensch-mcp-1-antikorper sowie antikorperfragment davon
|
AU2003264858A1
(en)
|
2002-09-30 |
2004-04-19 |
Given Imaging Ltd. |
Reduced size imaging device
|
ATE422203T1
(de)
|
2002-10-09 |
2009-02-15 |
Schering Corp |
Thiadiazoldioxide und thiadiazoloxide als cxc- und cc-chemokinrezeptor liganden
|
TWI250312B
(en)
|
2002-10-11 |
2006-03-01 |
Delta Electronics Inc |
Illumination system with multiple lamps
|
MXPA05004022A
(es)
|
2002-10-17 |
2005-10-05 |
Genmab As |
Anticuerpos monoclonales humanos contra cd20.
|
US7608684B2
(en)
|
2002-11-12 |
2009-10-27 |
Mochida Pharmaceuticals Co., Ltd. |
Soluble CD14 antigen
|
CA2506580C
(en)
|
2002-11-12 |
2010-08-17 |
Mochida Pharmaceutical Co., Ltd. |
Assay kit and antibody for human low molecular weight cd14
|
US7977471B2
(en)
|
2002-11-14 |
2011-07-12 |
Dharmacon, Inc. |
siRNA targeting TNFα
|
WO2006006948A2
(en)
|
2002-11-14 |
2006-01-19 |
Dharmacon, Inc. |
METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
|
US8658377B2
(en)
|
2002-11-15 |
2014-02-25 |
Morehouse School Of Medicine |
Detecting cancer with anti-CCL25 and anti-CCR9 antibodies
|
WO2004045512A2
(en)
|
2002-11-15 |
2004-06-03 |
Genmab A/S |
Human monoclonal antibodies against cd25
|
WO2004045526A2
(en)
|
2002-11-15 |
2004-06-03 |
Morehouse School Of Medicine |
Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
|
US9233120B2
(en)
|
2002-11-15 |
2016-01-12 |
Jyant Technologies |
Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration
|
US20070021466A1
(en)
|
2002-11-18 |
2007-01-25 |
Solomon Ungashe |
CCR2 inhibitors and methods of use thereof
|
CA2506949A1
(en)
|
2002-11-27 |
2004-06-10 |
Altana Pharma Ag |
Pde4 and pde3/4 inhibitors for use in the treatment of cachexia
|
ATE555087T1
(de)
|
2002-11-27 |
2012-05-15 |
Incyte Corp |
3-aminopyrrolidinderivate als modulatoren von chemokinrezeptoren
|
AU2003298015A1
(en)
|
2002-12-05 |
2004-06-30 |
Pdl Biopharma, Inc. |
Methods of treatment of ulcerative colitis with anti-cd3 antibodies
|
GB0228796D0
(en)
|
2002-12-11 |
2003-01-15 |
Adjuvantix Ltd |
Valency
|
US20040115647A1
(en)
|
2002-12-12 |
2004-06-17 |
Paterson Thomas S. |
Apparatus and method for identifying biomarkers using a computer model
|
MXPA05006354A
(es)
|
2002-12-13 |
2005-08-26 |
Smithkline Beecham Corp |
Antagonistas ccr5 como agentes terapeuticos.
|
AU2003299641C1
(en)
|
2002-12-16 |
2016-06-02 |
Cormorant Pharmaceuticals Ab |
Human monoclonal antibodies against interleukin 8 (IL-8)
|
EP1578260B1
(en)
|
2002-12-16 |
2012-10-24 |
Given Imaging Ltd. |
Device, system and method for selective activation of in vivo sensors
|
JP4549865B2
(ja)
|
2002-12-26 |
2010-09-22 |
ギブン イメージング リミテッド |
生体内画像化装置およびその製造方法
|
ATE547976T1
(de)
|
2002-12-26 |
2012-03-15 |
Given Imaging Ltd |
Immobilisierbare in-vivo messvorrichtung
|
US20050154277A1
(en)
|
2002-12-31 |
2005-07-14 |
Jing Tang |
Apparatus and methods of using built-in micro-spectroscopy micro-biosensors and specimen collection system for a wireless capsule in a biological body in vivo
|
DE10302501A1
(de)
|
2003-01-23 |
2004-08-05 |
Roche Diagnostics Gmbh |
Vorrichtung und Verfahren zur Aufnahme einer Körperflüssigkeit für Analysezwecke
|
KR20050098277A
(ko)
*
|
2003-01-29 |
2005-10-11 |
이-필 파마 리미티드 |
위장관 내 약물의 능동 송달
|
DE10305784A1
(de)
|
2003-02-12 |
2004-08-26 |
Merck Patent Gmbh |
Verfahren zur Herstellug bicyclischer aromatischer Aminosäuren sowie deren Zwischenprodukte
|
US20040242498A1
(en)
|
2003-02-27 |
2004-12-02 |
Collins Tassie L. |
CXCR3 antagonists
|
US20070148162A1
(en)
|
2003-02-27 |
2007-06-28 |
Ranjit Bhardwaj |
Molecule which binds cd80 and cd86
|
US8084582B2
(en)
|
2003-03-03 |
2011-12-27 |
Xencor, Inc. |
Optimized anti-CD20 monoclonal antibodies having Fc variants
|
JP4149838B2
(ja)
|
2003-03-04 |
2008-09-17 |
オリンパス株式会社 |
カプセル型医療装置
|
US20040185450A1
(en)
|
2003-03-21 |
2004-09-23 |
Heavner George A. |
MCP-1 mutant proteins, antibodies, compositions, methods and uses
|
US20040199054A1
(en)
|
2003-04-03 |
2004-10-07 |
Wakefield Glenn Mark |
Magnetically propelled capsule endoscopy
|
GB0307863D0
(en)
|
2003-04-04 |
2003-05-14 |
Merck Sharp & Dohme |
Therapeutic treatment
|
US7598243B2
(en)
|
2003-04-17 |
2009-10-06 |
Merck & Co., Inc. |
Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
|
US7611480B2
(en)
|
2003-04-24 |
2009-11-03 |
Levy Mark M |
Gastrointestinal bioreactor
|
EP1623010A4
(en)
|
2003-04-25 |
2007-12-26 |
Janssen Pharmaceutica Nv |
PRESERVATION OF RNA IN A BIOLOGICAL SAMPLE
|
JP4550048B2
(ja)
|
2003-05-01 |
2010-09-22 |
ギブン イメージング リミテッド |
パノラマ視野の撮像装置
|
AU2004252067B2
(en)
|
2003-05-09 |
2012-04-12 |
Duke University |
CD20-specific antibodies and methods of employing same
|
CN101052726A
(zh)
|
2003-05-09 |
2007-10-10 |
森托科尔公司 |
IL-23p40特异性免疫球蛋白衍生蛋白、组合物、方法和用途
|
AR044388A1
(es)
|
2003-05-20 |
2005-09-07 |
Applied Molecular Evolution |
Moleculas de union a cd20
|
JP2006528229A
(ja)
|
2003-05-22 |
2006-12-14 |
アルタナ ファルマ アクチエンゲゼルシャフト |
Pde4阻害剤及びpde5阻害剤を含有する組成物
|
EP1643906A2
(en)
|
2003-06-12 |
2006-04-12 |
University of Utah Research Foundation |
Apparatus, systems and methods for diagnosing carpal tunnel syndrome
|
ATE482235T1
(de)
|
2003-06-13 |
2010-10-15 |
Biogen Idec Inc |
Aglycosyl-anti-cd154 (cd40-ligand) antikörper und deren verwendungen
|
US7460896B2
(en)
|
2003-07-29 |
2008-12-02 |
Given Imaging Ltd. |
In vivo device and method for collecting oximetry data
|
US8147832B2
(en)
|
2003-08-14 |
2012-04-03 |
Merck Patent Gmbh |
CD20-binding polypeptide compositions and methods
|
JP4445732B2
(ja)
|
2003-08-29 |
2010-04-07 |
オリンパス株式会社 |
被検体内導入装置および無線型被検体内情報取得システム
|
US20050065441A1
(en)
|
2003-08-29 |
2005-03-24 |
Arkady Glukhovsky |
System, apparatus and method for measurement of motion parameters of an in-vivo device
|
JP2005074031A
(ja)
|
2003-09-01 |
2005-03-24 |
Pentax Corp |
カプセル内視鏡
|
AR045614A1
(es)
|
2003-09-10 |
2005-11-02 |
Hoffmann La Roche |
Anticuerpos contra el recepctor de la interleuquina- 1 y los usos de los mismos
|
EP1600164A3
(de)
|
2003-09-22 |
2006-05-17 |
TeGenero AG |
Verwendung einer an CD28 bindenden Wirksubstanz zur Herstellung einer Pharmazeutischen Zusammensetzung mit dosisabhängiger Wirkung
|
DE602004025157D1
(de)
|
2003-09-23 |
2010-03-04 |
Univ North Carolina |
Zellen, die Vitamin-K-Reduktase und Vitamin-K-abhängiges Protein coexprimieren und deren Anwendung zur Verbesserung der Produktivität von diesem Vitamin-K-abhängigen Protein
|
WO2005030793A2
(en)
|
2003-09-24 |
2005-04-07 |
Millennium Pharmaceuticals, Inc. |
Antibodies which bind human cxcr3
|
JP4733918B2
(ja)
*
|
2003-10-01 |
2011-07-27 |
オリンパス株式会社 |
カプセル投薬システム
|
ES2308227T3
(es)
|
2003-10-01 |
2008-12-01 |
Merck Patent Gmbh |
Antagonistas de integrina alfavbeta3 y alfavbeta6 como agentes antifibroticos.
|
US7759387B2
(en)
|
2003-10-08 |
2010-07-20 |
Piramal Life Sciences Limited |
Fibrinogen receptor antagonists and their use
|
AR046594A1
(es)
|
2003-10-16 |
2005-12-14 |
Applied Research Systems |
Usos terapeuticos de variantes de quemoquina
|
US8277810B2
(en)
|
2003-11-04 |
2012-10-02 |
Novartis Vaccines & Diagnostics, Inc. |
Antagonist anti-CD40 antibodies
|
EP1682537B1
(en)
|
2003-11-05 |
2012-03-28 |
SARcode Bioscience Inc. |
Modulators of cellular adhesion
|
US20050232923A1
(en)
|
2003-11-05 |
2005-10-20 |
Li Yan |
Methods and compositions for treating MCP-1 related pathologies
|
DE10352900A1
(de)
|
2003-11-11 |
2005-06-16 |
Tegenero Ag |
Verwendung einer an CD28 bindenden Wirksubstanz zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von B-CLL
|
WO2005046485A1
(en)
|
2003-11-12 |
2005-05-26 |
FäRGKLäMMAN AB |
Sampling device, method of producing a sampling device and use of a sampling device
|
EP1530950A1
(en)
|
2003-11-12 |
2005-05-18 |
Färgklämman AB |
Sampling device and method of producing thereof
|
ATE501173T1
(de)
|
2003-12-04 |
2011-03-15 |
Abbott Biotherapeutics Corp |
Anti-ip-10-antikörper
|
KR20130133302A
(ko)
|
2003-12-10 |
2013-12-06 |
메다렉스, 인코포레이티드 |
Ip―10 항체 및 그의 용도
|
GB2423472A
(en)
|
2003-12-11 |
2006-08-30 |
Univ Yale |
Methods and compositions relating to ccr5 antagonist,ifn-&gammed;and il-13 induced inflammation
|
US9392961B2
(en)
|
2003-12-17 |
2016-07-19 |
Check-Cap Ltd. |
Intra-lumen polyp detection
|
JP4851943B2
(ja)
|
2003-12-22 |
2012-01-11 |
シェーリング コーポレイション |
Cxc−ケモカインレセプターリガンドおよびcc−ケモカインレセプターリガンドとしてのイソチアゾールジオキシド
|
CN104013957B
(zh)
|
2003-12-23 |
2016-06-29 |
泰勒公司 |
用新的抗il13单克隆抗体治疗癌症
|
NZ548325A
(en)
|
2003-12-25 |
2009-07-31 |
Kirin Pharma Kk |
Mutants of anti-CD40 antibody
|
US7821564B2
(en)
|
2003-12-30 |
2010-10-26 |
Given Imaging Ltd. |
Assembly for aligning an optical system
|
US7647090B1
(en)
|
2003-12-30 |
2010-01-12 |
Given Imaging, Ltd. |
In-vivo sensing device and method for producing same
|
WO2005062716A2
(en)
|
2003-12-31 |
2005-07-14 |
Given Imaging Ltd. |
Apparatus, system and method to indicate in-vivo device location
|
US8206285B2
(en)
|
2003-12-31 |
2012-06-26 |
Given Imaging Ltd. |
Apparatus, system and method to indicate in-vivo device location
|
AU2005213449A1
(en)
|
2004-02-04 |
2005-08-25 |
The La Jolla Institute For Allergy And Immunology |
Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity
|
US20070122488A1
(en)
|
2004-02-25 |
2007-05-31 |
Erich Windhab |
Multi-functional microcapsules and method and device for manufacturing same
|
US7435831B2
(en)
|
2004-03-03 |
2008-10-14 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
DE602004010061T2
(de)
|
2004-03-09 |
2008-09-11 |
Infineon Technologies Ag |
Hochzuverlässige, kostengünstige und thermisch verbesserte Halbleiterchip-Befestigungstechnologie mit AuSn
|
DE602005014390D1
(de)
|
2004-03-25 |
2009-06-18 |
Olympus Corp |
Gerätesystem zur In-vivo-Informationserfassung
|
US20050260139A1
(en)
|
2004-03-30 |
2005-11-24 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions based on anticholinergics and CCR2 receptor antagonists
|
JP5128935B2
(ja)
|
2004-03-31 |
2013-01-23 |
ジェネンテック, インコーポレイテッド |
ヒト化抗TGF−β抗体
|
CN100376599C
(zh)
|
2004-04-01 |
2008-03-26 |
北京安波特基因工程技术有限公司 |
基因工程重组抗cea抗cd3抗cd28线性单链三特异抗体
|
US8024036B2
(en)
|
2007-03-19 |
2011-09-20 |
The Invention Science Fund I, Llc |
Lumen-traveling biological interface device and method of use
|
US9801527B2
(en)
|
2004-04-19 |
2017-10-31 |
Gearbox, Llc |
Lumen-traveling biological interface device
|
US7857767B2
(en)
|
2004-04-19 |
2010-12-28 |
Invention Science Fund I, Llc |
Lumen-traveling device
|
WO2005103081A2
(en)
|
2004-04-20 |
2005-11-03 |
Genmab A/S |
Human monoclonal antibodies against cd20
|
AU2005249383A1
(en)
|
2004-04-23 |
2005-12-15 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Cell death modulation via antagonists of FasL and Fas activation
|
CA2565519A1
(en)
|
2004-05-12 |
2005-12-01 |
Schering Corporation |
Cxcr1 and cxcr2 chemokine antagonists
|
EP1750676B1
(en)
|
2004-05-20 |
2014-07-23 |
Biosensors International Group, Ltd. |
Ingestible device platform for the colon
|
AU2005245224A1
(en)
|
2004-05-21 |
2005-12-01 |
Given Imaging Ltd. |
Device, system and method for in-vivo sampling
|
US7717874B2
(en)
*
|
2004-05-28 |
2010-05-18 |
Bioject, Inc. |
Needle-free injection system
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
SG155883A1
(en)
|
2004-06-03 |
2009-10-29 |
Novimmune Sa |
Anti-cd3 antibodies and methods of use thereof
|
AR049390A1
(es)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
US7938775B2
(en)
|
2004-06-28 |
2011-05-10 |
Given Imaging, Ltd. |
Device, system, and method for in-vivo analysis
|
CA2572289A1
(en)
|
2004-06-30 |
2006-08-17 |
Centocor, Inc. |
Anti-mcp-1 antibodies, compositions, methods and uses
|
US8500630B2
(en)
|
2004-06-30 |
2013-08-06 |
Given Imaging Ltd. |
In vivo device with flexible circuit board and method for assembly thereof
|
US7643865B2
(en)
|
2004-06-30 |
2010-01-05 |
Given Imaging Ltd. |
Autonomous in-vivo device
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
KR20070047327A
(ko)
|
2004-07-26 |
2007-05-04 |
비오겐 아이덱 엠에이 아이엔씨. |
항-cd154 항체
|
WO2006023420A2
(en)
|
2004-08-16 |
2006-03-02 |
Medimmune, Inc. |
Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity
|
EP1802660A2
(en)
|
2004-09-08 |
2007-07-04 |
Genentech, Inc. |
Methods of using death receptor ligands and cd20 antibodies
|
BRPI0515615A
(pt)
|
2004-09-08 |
2008-07-29 |
Genentech Inc |
métodos para tratar células cancerosas e doença imune relacionada
|
EP1808499B1
(en)
|
2004-09-14 |
2013-06-19 |
NTN Corporation |
High-frequency heat treatment apparatus, high-frequency heat treatment process, and high-frequency heat treated article
|
DK176145B1
(da)
|
2004-09-23 |
2006-10-02 |
Guldmann V As |
Kobling
|
AR051444A1
(es)
|
2004-09-24 |
2007-01-17 |
Centocor Inc |
Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
|
TWI306862B
(en)
|
2005-01-03 |
2009-03-01 |
Hoffmann La Roche |
Antibodies against il-13 receptor alpha 1 and uses thereof
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
JP2008526419A
(ja)
|
2005-01-18 |
2008-07-24 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
消化管内の流体を標本採取するための電子制御される摂取可能なカプセル
|
US8738106B2
(en)
|
2005-01-31 |
2014-05-27 |
Given Imaging, Ltd |
Device, system and method for in vivo analysis
|
US8852083B2
(en)
|
2005-02-04 |
2014-10-07 |
Uti Limited Partnership |
Self-stabilized encapsulated imaging system
|
LT1850873T
(lt)
|
2005-02-08 |
2019-04-10 |
Genzyme Corporation |
Antikūnas prieš tgf beta
|
US20070043320A1
(en)
|
2005-02-09 |
2007-02-22 |
Kenany Saad A |
Microstream injector
|
ITMI20050328A1
(it)
|
2005-03-03 |
2006-09-04 |
Univ Degli Studi Milano |
Composti peptidomimetrici e preparazione di derivati biologicamente attivi
|
DK2143795T3
(da)
|
2005-03-31 |
2011-09-19 |
Biomedics Inc |
Anti-CD20 monoklonalt antistof
|
US20090216082A1
(en)
|
2005-04-01 |
2009-08-27 |
Elisha Rabinovitz |
Device, System and Method for In Vivo Magnetic Immunoassay Analysis
|
TW200720289A
(en)
|
2005-04-01 |
2007-06-01 |
Hoffmann La Roche |
Antibodies against CCR5 and uses thereof
|
DE102005015522A1
(de)
|
2005-04-04 |
2006-10-05 |
Karl Storz Gmbh & Co. Kg |
Intrakorporale Videokapsel mit schwenkbarem Bildaufnehmer
|
US8475794B2
(en)
|
2005-04-06 |
2013-07-02 |
Ibc Pharmaceuticals, Inc. |
Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases
|
GB0507696D0
(en)
|
2005-04-15 |
2005-05-25 |
Novartis Ag |
Organic compounds
|
WO2007054128A1
(en)
|
2005-11-14 |
2007-05-18 |
Dominion Pharmakine S.L. |
Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof
|
GB0507918D0
(en)
|
2005-04-19 |
2005-05-25 |
Novartis Ag |
Organic compounds
|
AU2006236417B2
(en)
|
2005-04-20 |
2011-02-03 |
Amgen Fremont Inc. |
High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies
|
US20060257411A1
(en)
|
2005-05-06 |
2006-11-16 |
Bruce Beutler |
Compositions and methods for modulating cells via CD14 and toll-like receptor 4 signaling pathway
|
KR20080005601A
(ko)
|
2005-05-11 |
2008-01-14 |
니코메드 게엠베하 |
Pde4 억제제 로플루밀라스트와 테트라히드로비오프테린유도체의 조합
|
US8114964B2
(en)
|
2005-05-19 |
2012-02-14 |
Centocor, Inc. |
Anti-MCP-1 antibodies, compositions, methods and uses
|
MX2007014267A
(es)
|
2005-05-20 |
2008-02-07 |
Elan Pharm Inc |
Derivados de imidazolona fenilamina como antagonistas vla-4.
|
BRPI0610203A2
(pt)
|
2005-05-24 |
2010-06-01 |
Avestha Gengraine Tech Pvt Ltd |
processo de preparação in vivo de anti-corpo monoclonal anti-cd 20 biologicamente ativo e composição farmacêutica
|
US20070014720A1
(en)
|
2005-06-02 |
2007-01-18 |
Gadi Gazit-Bornstein |
Antibodies directed to CD20 and uses thereof
|
CN103665168A
(zh)
|
2005-06-03 |
2014-03-26 |
持田制药株式会社 |
抗cd14抗体融合蛋白质
|
MX2007016032A
(es)
|
2005-06-21 |
2008-03-10 |
Xoma Technology Ltd |
Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
|
CA2613818C
(en)
|
2005-06-30 |
2013-08-27 |
Centocor, Inc. |
Anti-il-23 antibodies, compositions, methods and uses
|
CA2616010C
(en)
|
2005-07-20 |
2013-11-05 |
Neil R. Euliano |
Medication compliance system and associated methods
|
SI1912675T1
(sl)
|
2005-07-25 |
2014-07-31 |
Emergent Product Development Seattle, Llc |
zmanjšanje števila celic B z uporabo molekul, ki se specifično vežejo na CD37 in CD20
|
CN101267836A
(zh)
|
2005-07-25 |
2008-09-17 |
特鲁比昂药品公司 |
单剂量cd20特异性结合分子的用途
|
US20070027362A1
(en)
|
2005-07-27 |
2007-02-01 |
Olympus Medical Systems Corp. |
Infrared observation system
|
US8591457B2
(en)
*
|
2005-08-10 |
2013-11-26 |
Alza Corporation |
Method for making a needle-free jet injection drug delivery device
|
CA2625815A1
(en)
|
2005-09-12 |
2007-03-22 |
Novimmune S.A. |
Anti-cd3 antibody formulations
|
WO2007033291A2
(en)
|
2005-09-14 |
2007-03-22 |
The Trustees Of Columbia University In The City Of New York |
Regulatory cd8+t cells induced with anti-cd3 antibody
|
EP1940836A1
(en)
|
2005-09-29 |
2008-07-09 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
|
CN101282677B
(zh)
|
2005-10-05 |
2010-07-28 |
奥林巴斯医疗株式会社 |
胶囊式医疗装置、其引导系统和引导方法、及被检体内插入装置
|
GB0520378D0
(en)
|
2005-10-06 |
2005-11-16 |
Novartis Ag |
Organic compounds
|
GB0521200D0
(en)
|
2005-10-19 |
2005-11-23 |
Reckitt Benckiser Au Pty Ltd |
Chemical formulation supply unit for a vapour emanating device
|
KR20080049113A
(ko)
|
2005-10-21 |
2008-06-03 |
노파르티스 아게 |
Il-13에 대항한 인간 항체 및 치료적 용도
|
US20070092401A1
(en)
|
2005-10-26 |
2007-04-26 |
Feier Liao |
Devices and methods for sample collection and analysis
|
EP2210632B1
(en)
*
|
2005-11-02 |
2012-01-18 |
Injectica AG |
Implantable infusion device with advanceable and retractable needle
|
EP1959958A4
(en)
|
2005-11-14 |
2010-07-14 |
Univ Southern California |
INTEGRIN-BINDING SMALL MOLECULES
|
EP1954197A2
(en)
|
2005-11-22 |
2008-08-13 |
Stichting Top Institute Food and Nutrition |
Sampling device for in vivo sampling of liquids from the gastrointestinal tract, process for the production thereof and mould or mask for use in the production process
|
EP1961750B1
(en)
|
2005-12-13 |
2013-09-18 |
Daiichi Sankyo Company, Limited |
Vla-4 inhibitory drug
|
US8673873B1
(en)
|
2005-12-28 |
2014-03-18 |
Alcon Research, Ltd. |
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders
|
EP1965698B1
(en)
|
2005-12-29 |
2014-02-19 |
Given Imaging Ltd. |
System and method of in-vivo magnetic position determination
|
US7510844B2
(en)
|
2006-01-24 |
2009-03-31 |
Bristol-Myers Squibb Company |
CD86 and CD80 receptor competition assays
|
US10344095B2
(en)
|
2006-02-16 |
2019-07-09 |
University Of Kentucky Research Foundation |
CCR3 inhibition for ocular angiogenesis and macular degeneration
|
EA017110B1
(ru)
|
2006-02-27 |
2012-09-28 |
Элан Фамэсьютикэлс, Инк. |
ПИРИМИДИНИЛСУЛЬФОНАМИДНЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ ПИРИМИДИНИЛСУЛЬФОНАМИДНЫХ СОЕДИНЕНИЙ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДОВАННОГО ИНТЕГРИНОМ α4, СПОСОБ СНИЖЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ВОСПАЛИТЕЛЬНОГО КОМПОНЕНТА ЗАБОЛЕВАНИЯ ИЛИ АУТОИММУННОГО ОТВЕТА
|
WO2007102200A1
(ja)
|
2006-03-07 |
2007-09-13 |
Osaka University |
抗cd20モノクローナル抗体
|
BRPI0709338A2
(pt)
|
2006-03-21 |
2011-07-12 |
Genentech Inc |
anticorpo, molécula de ácido nucleico isolada, célula, composições, método de detecção da proteìna alfa5beta1, uso de anticorpo, métodos de tratamento, kit, uso de uma composição, uso de uma antagonista de alfa5beta e uso de uma antagonista de vegf
|
IL182332A
(en)
|
2006-03-31 |
2013-04-30 |
Given Imaging Ltd |
A system and method for assessing a patient's condition
|
DE102006030434A1
(de)
*
|
2006-05-03 |
2007-11-08 |
CFS Bühl GmbH |
Zuführvorrichtung für einen Traysealer
|
US7727525B2
(en)
|
2006-05-11 |
2010-06-01 |
City Of Hope |
Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics
|
TW200813084A
(en)
|
2006-05-16 |
2008-03-16 |
Univ Saskatchewan |
High-affinity antagonists of ELR-CXC chemokines
|
EP2041568A4
(en)
|
2006-06-15 |
2009-08-12 |
|
CCR2 ANTAGONISTS FOR CHRONIC BREATHING REACTIONS IN ORGAN TRANSPLANTATIONS
|
ATE422375T1
(de)
|
2006-06-15 |
2009-02-15 |
Ela Medical Sa |
Aktives medizinisches implantat, insbesondere vorrichtung zur stimulation, resynchronisation, defibrillation und/oder kardioversion, die mittel zur prädiktiven warnung über eine verschlimmerung des krankheitszustands des patienten umfasst
|
WO2007148238A1
(en)
|
2006-06-20 |
2007-12-27 |
Koninklijke Philips Electronics, N.V. |
Electronic capsule for treating gastrointestinal disease
|
WO2008002933A2
(en)
|
2006-06-26 |
2008-01-03 |
Macrogenics, Inc. |
Combination of fcgammariib antibodies and cd20-specific antibodies and methods of use thereof
|
WO2008003319A1
(en)
|
2006-07-04 |
2008-01-10 |
Genmab A/S |
Cd20 binding molecules for the treatment of copd
|
PL2363130T3
(pl)
|
2006-07-05 |
2014-09-30 |
Astrazeneca Ab |
Kombinacja inhibitorów reduktazy HMG-CoA atorwastatyny i symwastatyny z inhibitorem fosfodiesterazy, takim jak roflumilast do leczenia zapalnych chorób płuc
|
DE602007012261D1
(de)
|
2006-07-14 |
2011-03-10 |
Chemocentryx Inc |
Triazolyl-pyridyl-benzolsulfonamide als ccr2- oder ccr9-modulatoren zur behandlung von atherosklerose
|
BRPI0715141A2
(pt)
|
2006-08-03 |
2013-06-04 |
Astrazeneca Ab |
agente de ligaÇço alvejante, anticorpo isolado, fragmento de anticorpo isolado, molÉcula de Ácido nucleico, vetor, cÉlula hospedeira, mÉtodos para produzir um agente de ligaÇço alvejado, para produzir um anticorpo, para produzir um fragmento de anticorpo, para tratar um tumor maligno em um animal, para tratar inflamaÇço, e para inibir a interaÇço de alfabeta6 com seu ligando, e, conjugado
|
WO2008022153A2
(en)
|
2006-08-14 |
2008-02-21 |
The Regents Of The University Of California |
Inhibitors of pde4 and methods of use
|
TW200817438A
(en)
|
2006-08-17 |
2008-04-16 |
Hoffmann La Roche |
A conjugate of an antibody against CCR5 and an antifusogenic peptide
|
NZ575163A
(en)
|
2006-08-28 |
2011-12-22 |
Jolla Inst Allergy Immunolog |
Antagonistic human light-specific human monoclonal antibodies
|
WO2008030482A2
(en)
|
2006-09-06 |
2008-03-13 |
Innurvation Inc |
System and method for acoustic information exchange involving an ingestible low power capsule
|
US8213698B2
(en)
|
2006-09-19 |
2012-07-03 |
Capso Vision Inc. |
Systems and methods for capsule camera control
|
EP2068696B1
(en)
|
2006-09-25 |
2018-09-26 |
Progenity, Inc. |
Medicament delivery apparatus
|
NZ597098A
(en)
|
2006-09-28 |
2013-05-31 |
Merck Sharp & Dohme |
Use of pegylated il-10 to treat cancer
|
JP4960459B2
(ja)
|
2006-09-29 |
2012-06-27 |
エフ.ホフマン−ラ ロシュ アーゲー |
Ccr5に対する抗体およびその使用
|
MX2009003762A
(es)
|
2006-10-05 |
2009-07-10 |
Centocor Ortho Biotech Inc |
Antagonistas del receptor cc-quimiocina 2 para el tratamiento de fibrosis.
|
US7547293B2
(en)
*
|
2006-10-06 |
2009-06-16 |
Bioject, Inc. |
Triggering mechanism for needle-free injector
|
US9382327B2
(en)
|
2006-10-10 |
2016-07-05 |
Vaccinex, Inc. |
Anti-CD20 antibodies and methods of use
|
US8178100B2
(en)
|
2006-10-13 |
2012-05-15 |
Seoul National University Industry Foundation |
Antibodies to IP-10 for treating bone diseases with bone destruction
|
CN101534711B
(zh)
*
|
2006-10-31 |
2012-11-14 |
皇家飞利浦电子股份有限公司 |
用于在胃肠道中释放药物的可吞吃的多喷嘴给药设备的设计
|
WO2008060621A2
(en)
|
2006-11-17 |
2008-05-22 |
Abbott Laboratories |
Aminopyrrolidines as chemokine receptor antagonists
|
EP2094158B1
(en)
*
|
2006-11-21 |
2018-05-02 |
STOCO 10 GmbH |
Ingestible electronic capsule and in vivo drug delivery or diagnostic system
|
CN101622773B
(zh)
|
2007-02-26 |
2012-05-23 |
奥林巴斯医疗株式会社 |
磁驱动器、磁驱动器的工作方法及采用该磁驱动器的胶囊型内窥镜
|
US8258267B2
(en)
|
2007-02-28 |
2012-09-04 |
Novimmune S.A. |
Human anti-IP-10 antibodies uses thereof
|
US9730573B2
(en)
|
2007-03-20 |
2017-08-15 |
Given Imaging Ltd. |
Narrow band in-vivo imaging device
|
EA019636B1
(ru)
|
2007-03-22 |
2014-05-30 |
Байоджен Айдек Ма Инк. |
Связывающие белки, включающие антитела, производные антител и фрагменты антител, которые специфически связываются с cd154, и их применения
|
JP4932588B2
(ja)
|
2007-05-08 |
2012-05-16 |
オリンパス株式会社 |
画像処理装置および画像処理プログラム
|
AU2008266952A1
(en)
|
2007-06-12 |
2008-12-24 |
Trubion Pharmaceuticals, Inc. |
Anti-CD20 therapeutic compositions and methods
|
AU2008270438B2
(en)
|
2007-07-02 |
2013-10-10 |
F. Hoffmann-La Roche Ag |
Imidazole derivatives as CCR2 receptor antagonists
|
DK2175859T3
(da)
|
2007-07-12 |
2012-06-18 |
Chemocentryx Inc |
Kondenserede heteroarylpyridyl- og phenylbenzen-sulfonamider som ccr2-modulatorer til behandling af inflammation
|
BRPI0815567B8
(pt)
|
2007-07-17 |
2021-05-25 |
Merck Patent Gessellschaft Mit Beschraenkter Haftung |
anticorpos híbridos anti-alfa v-integrina projetados, proteína de fusão e composição farmacêutica
|
WO2009010429A2
(en)
|
2007-07-19 |
2009-01-22 |
F. Hoffmann-La Roche Ag |
Novel heterocyclyl compounds and their use as chemokine antagonists
|
US7977358B2
(en)
|
2007-07-26 |
2011-07-12 |
Hoffmann-La Roche Inc. |
Pyrazol derivatives
|
US20090028866A1
(en)
|
2007-07-27 |
2009-01-29 |
John Wayne Cancer Institute |
USE OF CCR9, CCL25/TECK, AND NITEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE
|
MY147651A
(en)
|
2007-07-31 |
2012-12-31 |
Regeneron Pharma |
Human antibodies to human cd20 and method of using thereof
|
WO2009030368A1
(en)
|
2007-09-05 |
2009-03-12 |
F. Hoffmann-La Roche Ag |
Combination therapy with type i and type ii anti-cd20 antibodies
|
WO2009031230A1
(ja)
|
2007-09-06 |
2009-03-12 |
Osaka University |
抗cd20モノクローナル抗体
|
WO2009043747A2
(en)
|
2007-10-01 |
2009-04-09 |
F. Hoffmann-La Roche Ag |
N-heterocyclic biaryl carboxamides as ccr receptor antagonists
|
US8008092B2
(en)
|
2007-10-09 |
2011-08-30 |
University Of Kentucky Research Foundation |
CCR3 inhibition for ocular angiogenesis and macular degeneration
|
EP2050764A1
(en)
|
2007-10-15 |
2009-04-22 |
sanofi-aventis |
Novel polyvalent bispecific antibody format and uses thereof
|
US20090098118A1
(en)
|
2007-10-15 |
2009-04-16 |
Thomas Friess |
Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent
|
US20100285475A1
(en)
|
2007-10-22 |
2010-11-11 |
Agency For Science, Technology And Research |
Fused genes
|
US20090110688A1
(en)
|
2007-10-24 |
2009-04-30 |
Georg Fertig |
Combination therapy of type ii anti-cd20 antibody with a proteasome inhibitor
|
US8168829B2
(en)
|
2007-10-26 |
2012-05-01 |
Janssen Pharmaceutica N.V. |
Synthesis of quaternary salt compounds
|
ES2620816T3
(es)
|
2007-11-12 |
2017-06-29 |
Novineon Healthcare Technology Partners Gmbh |
Dispositivo para la detección de hemorragias
|
EP2217314B1
(en)
|
2007-11-29 |
2013-07-17 |
Boston Scientific Scimed, Inc. |
Drainage catheter
|
US20090180951A1
(en)
|
2007-12-12 |
2009-07-16 |
Molecular Insight Pharmaceuticals, Inc. |
Inhibitors of integrin vla-4
|
CA2708951A1
(en)
|
2007-12-21 |
2009-07-09 |
Genetech, Inc. |
Crystallization of anti-cd20 antibodies
|
US7914785B2
(en)
|
2008-01-02 |
2011-03-29 |
Bergen Teknologieverforing As |
B-cell depleting agents, like anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome
|
CN101918451A
(zh)
|
2008-01-15 |
2010-12-15 |
弗·哈夫曼-拉罗切有限公司 |
抗CCR5的afucosylated抗体及其用途
|
WO2009094391A1
(en)
|
2008-01-23 |
2009-07-30 |
Xencor, Inc. |
Optimized cd40 antibodies and methods of using the same
|
CN101945613B
(zh)
|
2008-02-18 |
2014-08-13 |
皇家飞利浦电子股份有限公司 |
为患者用药
|
EP2259714B1
(en)
|
2008-02-22 |
2019-09-11 |
NanoMed Diagnostics B.V. |
Device for detecting a medical condition or disease
|
US20100111763A1
(en)
|
2008-03-18 |
2010-05-06 |
Kahn Laurence H |
Examination Device for Blood Detection
|
TWI500624B
(zh)
|
2008-03-25 |
2015-09-21 |
Hoffmann La Roche |
具有增進之抗體依賴型細胞毒性之第ii型抗-cd20抗體之組合療法
|
WO2009137471A2
(en)
|
2008-05-05 |
2009-11-12 |
University Of Miami |
Azo dye related small molecule modulators of protein-protein interactions
|
US8636653B2
(en)
|
2008-06-09 |
2014-01-28 |
Capso Vision, Inc. |
In vivo camera with multiple sources to illuminate tissue at different distances
|
US9538937B2
(en)
|
2008-06-18 |
2017-01-10 |
Covidien Lp |
System and method of evaluating a subject with an ingestible capsule
|
US8961498B2
(en)
|
2008-06-25 |
2015-02-24 |
Medimetrics Personalized Drug Delivery |
Electronic pill comprising a plurality of medicine reservoirs
|
CN102088955A
(zh)
|
2008-07-07 |
2011-06-08 |
皇家飞利浦电子股份有限公司 |
包括储药器的电子药丸
|
US8423122B2
(en)
|
2008-07-10 |
2013-04-16 |
Given Imaging Ltd. |
Localization of capsule with a synthetic source of quadrupoles and dipoles
|
CA2730316A1
(en)
|
2008-07-11 |
2010-01-14 |
Phylogica Limited |
Peptide inhibitors of cd40l signaling and uses therefor
|
US8262566B2
(en)
|
2008-07-14 |
2012-09-11 |
Given Imaging Ltd. |
Device and method for uniform in vivo illumination
|
PL2700651T3
(pl)
|
2008-07-18 |
2019-09-30 |
Bristol-Myers Squibb Company |
Kompozycje jednowartościowe dla wiązania cd28 i sposoby stosowania
|
US20110097339A1
(en)
|
2008-07-18 |
2011-04-28 |
Domantis Limited |
Compositions monovalent for CD28 binding and methods of use
|
SG193216A1
(en)
|
2008-08-18 |
2013-09-30 |
Amgen Fremont Inc |
Antibodies to ccr2
|
EP2328930B1
(en)
|
2008-08-20 |
2014-12-24 |
Probiodrug AG |
Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe)
|
WO2010021874A2
(en)
|
2008-08-20 |
2010-02-25 |
Centocor Ortho Biotech Inc. |
Engineered anti-il-13 antibodies, compositions, methods and uses
|
US20100055098A1
(en)
|
2008-08-28 |
2010-03-04 |
Facet Biotech Corporation |
Method for treating multiple sclerosis patients with anti-il2r antibodies
|
EP2166009A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as nadph oxidase inhibitors
|
EP2344540B1
(en)
|
2008-10-02 |
2017-11-29 |
Aptevo Research and Development LLC |
Cd86 antagonist multi-target binding proteins
|
AU2009312532B2
(en)
|
2008-11-06 |
2013-05-16 |
Ichnos Sciences SA |
Treatment with anti-alpha2 integrin antibodies
|
KR101588547B1
(ko)
|
2008-11-11 |
2016-01-28 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
항-cxcr1 조성물 및 방법
|
PT2379115T
(pt)
|
2008-12-17 |
2018-01-03 |
Merck Sharp & Dohme |
Produção de mono- e di-peg-il-10; e utilizações
|
ES2468391T3
(es)
|
2008-12-22 |
2014-06-16 |
Millennium Pharmaceuticals, Inc. |
Combinación de inhibidores de cinasas Aurora y anticuerpos anti-CD20
|
FR2940616A1
(fr)
|
2008-12-30 |
2010-07-02 |
Lfb Biotechnologies |
Utilisation d'un anticorps anti-cd20 pour le traitement du lymphome primaire intraoculaire.
|
EP2382463B1
(en)
|
2009-01-29 |
2016-05-25 |
Given Imaging Ltd. |
Device,system and method for detection of bleeding
|
DE102009009165B4
(de)
|
2009-02-16 |
2018-12-27 |
Siemens Healthcare Gmbh |
Verfahren und Vorrichtung zur Bestimmung eines von einer Endoskopiekapsel in einem Patienten zurückgelegten Weges
|
JP2012517806A
(ja)
|
2009-02-16 |
2012-08-09 |
バイオレックス・セラピューティクス インコーポレイテッド |
ヒト化抗cd20抗体および使用方法
|
US8679492B2
(en)
|
2009-02-23 |
2014-03-25 |
Glenmark Pharmaceuticals S.A. |
Humanized antibodies that bind to CD19 and their uses
|
EP2677036A3
(en)
|
2009-02-25 |
2014-01-22 |
Diagnocure Inc. |
Method for predicting the risk of cancer recurrence
|
US9161927B2
(en)
|
2009-02-27 |
2015-10-20 |
Boehringer Ingelheim International Gmbh |
Drug combinations containing PDE4 inhibitors and NSAIDs
|
CA2753597A1
(en)
|
2009-02-27 |
2010-09-02 |
Boehringer Ingelheim International Gmbh |
Drug combinations containing pde4-inhibitors and nsaids
|
EP2413786B1
(en)
|
2009-03-31 |
2015-05-20 |
Given Imaging, Inc., |
Method of determining body exit of an ingested capsule
|
KR100931946B1
(ko)
|
2009-06-10 |
2009-12-15 |
주식회사 인트로메딕 |
캡슐 내시경에 의해 촬영된 이미지 데이터를 저장하고 있는 서버로부터 관심있는 데이터를 우선하여 단말기에 수신하여 확인할 수 있도록 하는 서버-클라이언트 시스템의 이미지 데이터 전송 프로세싱 방법
|
US20120184827A1
(en)
|
2009-06-16 |
2012-07-19 |
Shoulamit Cohen Shwartz |
Miniature disease optical spectroscopy diagnostic system
|
CN101967192B
(zh)
|
2009-07-28 |
2013-01-23 |
中国医学科学院医药生物技术研究所 |
抗cd20抗体片段与力达霉素的融合蛋白、制备方法及其用途
|
WO2011016002A1
(en)
|
2009-08-05 |
2011-02-10 |
Tel Hashomer Medical Research Infrastructure And Services, Ltd. |
Methods and devices for providing information useful in the diagnosis of abnormalities of the gastrointestinal tract
|
WO2011019679A1
(en)
|
2009-08-11 |
2011-02-17 |
Allergan, Inc. |
Ccr2 inhibitors for treating conditions of the eye
|
TWI409079B
(zh)
|
2009-08-14 |
2013-09-21 |
Roche Glycart Ag |
非典型岩藻醣化cd20抗體與苯達莫斯汀(bendamustine)之組合療法
|
JP2013501741A
(ja)
|
2009-08-14 |
2013-01-17 |
ロシュ グリクアート アーゲー |
アフコシル化cd20抗体とフルダラビン及び/又はミトキサントロンの併用療法
|
JP6109571B2
(ja)
|
2009-08-28 |
2017-04-05 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
複数種のCCケモカインと結合するantikine抗体
|
US20130018279A1
(en)
|
2009-09-01 |
2013-01-17 |
Pathway Genomics |
"blood sample collection apparatus and kits"
|
FR2951176A1
(fr)
|
2009-10-09 |
2011-04-15 |
Tcl Pharma |
Ligands monovalents du recepteur cd28 humain
|
LT3037104T
(lt)
|
2009-10-20 |
2020-09-10 |
Abbvie Inc. |
Anti-il-13 antikūnų izoliavimas ir gryninimas, naudojant afininę baltymo a chromatografiją
|
US20110091824A1
(en)
|
2009-10-20 |
2011-04-21 |
Vinayak Barve |
Method of operating a multi-fuel combustion system
|
CA2778334A1
(en)
|
2009-10-20 |
2011-04-28 |
Charlotte Mckee |
Anti-cd3 antibody dosing in autoimmune disease
|
WO2011051276A1
(en)
|
2009-10-26 |
2011-05-05 |
Externautics S.P.A. |
Colon and rectal tumor markers and methods of use thereof
|
US9026192B2
(en)
|
2009-11-24 |
2015-05-05 |
Given Imaging Ltd |
Device and method for in vivo imaging
|
EP2515992B1
(en)
*
|
2009-12-24 |
2018-10-10 |
Rani Therapeutics, LLC |
Swallowable drug delivery device
|
US8296093B2
(en)
|
2009-12-30 |
2012-10-23 |
Infineon Technologies Ag |
Semiconductor device with thermal fault detection
|
US20160208011A1
(en)
|
2010-01-28 |
2016-07-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same
|
TW201129383A
(en)
|
2010-02-10 |
2011-09-01 |
Immunogen Inc |
CD20 antibodies and uses thereof
|
CN105001334A
(zh)
|
2010-02-10 |
2015-10-28 |
伊缪诺金公司 |
Cd20抗体及其用途
|
ITFI20100019A1
(it)
|
2010-02-12 |
2011-08-13 |
Univ Firenze |
Inibitori peptidomimetici di integrine basati sull'1,2,3-triazolo per la diagnosi e terapia dei tumori.
|
DK2536764T3
(en)
|
2010-02-18 |
2018-09-17 |
Ose Immunotherapeutics |
ANTI-CD28 HUMANIZED ANTIBODIES
|
EP3590966A1
(en)
|
2010-02-23 |
2020-01-08 |
Sanofi |
Anti-alpha2 integrin antibodies and their uses
|
WO2011109588A1
(en)
|
2010-03-03 |
2011-09-09 |
Health Research Inc. |
Novel cd3 epsilon immunogens and antibodies
|
US9616120B2
(en)
|
2010-03-04 |
2017-04-11 |
Vet Therapeutics, Inc. |
Monoclonal antibodies directed to CD20
|
EP2571573A4
(en)
|
2010-03-17 |
2013-12-04 |
Photopill Medical Ltd |
PHOTOTHERAPY BY CAPSULE
|
CN102190728B
(zh)
|
2010-03-17 |
2014-07-02 |
永卓博济(上海)生物医药技术有限公司 |
一种人源化抗cd20单克隆抗体
|
WO2011115688A2
(en)
|
2010-03-19 |
2011-09-22 |
H. Lee Moffitt Cancer Center & Research Institute |
Integrin interaction inhibitors for the treatment of cancer
|
HUE038788T2
(hu)
|
2010-03-31 |
2018-11-28 |
Boehringer Ingelheim Int |
Anti-CD40 antitestek
|
WO2011124524A1
(de)
|
2010-04-08 |
2011-10-13 |
Boehringer Ingelheim International Gmbh |
Arzneimittelkombinationen enthaltend pde4-inhibitoren und ep4-rezeptor-antagonisten
|
EP2555774B1
(de)
|
2010-04-08 |
2015-10-21 |
Boehringer Ingelheim International GmbH |
Arnzeimittelkombinationen enthaltend pde4-inhibitoren und ep4-rezeptor-antagonisten
|
KR101620661B1
(ko)
|
2010-04-27 |
2016-05-12 |
로슈 글리카트 아게 |
어푸코실화된 CD20 항체와 mTOR 억제제의 복합 요법
|
US20130078238A1
(en)
|
2010-04-29 |
2013-03-28 |
Hadasit Medical Research Services & Decvelopment Co. Ltd. |
Methods and Compositions for Treating Hepatitis with Anti-CD3 Immune Molecule Therapy
|
JP2013525435A
(ja)
|
2010-04-30 |
2013-06-20 |
エラン ファーマシューティカルズ,インコーポレイテッド |
選択的インテグリン阻害剤
|
AR082693A1
(es)
|
2010-08-17 |
2012-12-26 |
Roche Glycart Ag |
Terapia de combinacion de un anticuerpo anti-cd20 afucosilado con un anticuerpo anti-vegf
|
GB201013989D0
(en)
|
2010-08-20 |
2010-10-06 |
Univ Southampton |
Biological materials and methods of using the same
|
AR083847A1
(es)
|
2010-11-15 |
2013-03-27 |
Novartis Ag |
Variantes de fc (fragmento constante) silenciosas de los anticuerpos anti-cd40
|
CN103209632B
(zh)
|
2010-11-16 |
2017-03-15 |
基文影像公司 |
用于执行光谱分析的体内成像装置和方法
|
US8969293B2
(en)
|
2010-12-23 |
2015-03-03 |
Rani Therapeutics, Llc |
Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8809271B2
(en)
*
|
2010-12-23 |
2014-08-19 |
Rani Therapeutics, Llc |
Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9415004B2
(en)
|
2010-12-23 |
2016-08-16 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
WO2012093127A2
(en)
|
2011-01-04 |
2012-07-12 |
Universität Zürich |
Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease
|
CA2821926A1
(en)
|
2011-01-07 |
2012-07-12 |
Abbvie Inc. |
Anti-il-12/il-23 antibodies and uses thereof
|
US20120208755A1
(en)
*
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
AU2012229236B2
(en)
|
2011-03-11 |
2017-05-18 |
Beth Israel Deaconess Medical Center, Inc. |
Anti-CD40 antibodies and uses thereof
|
CN103209634B
(zh)
|
2011-04-01 |
2016-02-03 |
奥林巴斯株式会社 |
接收装置和胶囊型内窥镜系统
|
CA2832281C
(en)
|
2011-04-04 |
2019-11-05 |
Trustees Of Dartmouth College |
Anti-cd154 antibodies having impaired fcr binding and/or complement binding properties and the use thereof in immune therapies
|
US9028826B2
(en)
|
2011-04-04 |
2015-05-12 |
The Trustees Of Dartmouth College |
Methods of immune therapy with anti-CD154 antibodies having impaired FcR binding and/or complement binding properties
|
US8586384B2
(en)
|
2011-04-05 |
2013-11-19 |
Olympus Corporation |
Method of collecting duodenal specimen to detect upper digestive system disease without using pancreatic or bile stimulant
|
US20140178367A1
(en)
|
2011-04-07 |
2014-06-26 |
The Brigham And Women's Hospital, Inc. |
Methods of Treating Inflammatory Diseases by Targeting the Chemoattractant Cytokine Receptor 2 (CCR2) or Chemokine (C-C motif) Ligand 2 (CCL2)
|
CN103619880A
(zh)
|
2011-04-29 |
2014-03-05 |
百时美施贵宝公司 |
Ip-10抗体剂量递增方法
|
BR122016016837A2
(pt)
|
2011-05-21 |
2019-08-27 |
Macrogenics Inc |
moléculas de ligação a cd3; anticorpos de ligação a cd3; composições farmacêuticas; e usos da molécula de ligação a cd3
|
EP3257519B8
(en)
|
2011-06-27 |
2020-06-03 |
Sorbonne Universite |
Ccr2 antagonist peptides
|
ES2773115T3
(es)
*
|
2011-06-29 |
2020-07-09 |
Rani Therapeutics Llc |
Preparados de agentes terapéuticos para la administración hacia el interior de una luz del tubo intestinal utilizando un dispositivo tragable para la administración de fármacos
|
KR20140061379A
(ko)
|
2011-07-06 |
2014-05-21 |
모르포시스 아게 |
항cd20 및 항gmcsf 항체의 치료 조합물 및 이의 용도
|
SG10201505454SA
(en)
|
2011-07-13 |
2015-09-29 |
Abbvie Inc |
Methods and compositions for treating asthma using anti-il-13 antibodies
|
CN103827668B
(zh)
|
2011-08-04 |
2016-04-20 |
基文影像公司 |
用于体内免疫测定的装置、系统和方法
|
NZ620635A
(en)
|
2011-08-17 |
2015-09-25 |
Piramal Imaging Sa |
Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi
|
CN106526186A
(zh)
|
2011-09-12 |
2017-03-22 |
克里蒂科斯有限责任公司 |
检测靶分子的非侵入性方法
|
US8884006B2
(en)
|
2011-09-19 |
2014-11-11 |
University Of Puerto Rico |
Small-molecule inhibitors of Rac1 in metastatic breast cancer
|
US8801630B2
(en)
|
2011-09-30 |
2014-08-12 |
Olympus Medical Systems Corp. |
Method of taking out liquid present inside subject therefrom
|
JO3370B1
(ar)
|
2011-11-10 |
2019-03-13 |
Regeneron Pharma |
طريقة لتثبيط نمو الورم عن طريق تثبيط مستقبل انترلوكين 6
|
EP2591782A1
(en)
|
2011-11-11 |
2013-05-15 |
Johann Wolfgang Goethe-Universität |
Nadph oxidase 4 inhibitors and use thereof
|
US9795330B2
(en)
|
2011-12-15 |
2017-10-24 |
Given Imaging Ltd. |
Device, system and method for in-vivo detection of bleeding in the gastrointestinal tract
|
EP2790564A4
(en)
|
2011-12-15 |
2016-06-08 |
Given Imaging Ltd |
DEVICE, SYSTEM AND METHOD FOR IN VIVO DETECTION OF BLEEDINGS IN THE STOMACH DARM TRACT
|
US20140004037A1
(en)
|
2012-01-19 |
2014-01-02 |
Therapeutic Proteins, Inc. |
Stabilization of the anti-cd20 antibody rituximab
|
WO2013120184A1
(en)
|
2012-02-17 |
2013-08-22 |
Micropharma Limited |
Ingestible medical device
|
US20150038678A1
(en)
|
2012-02-29 |
2015-02-05 |
Ambrx, Inc. |
Interleukin-10 Polypeptide Conjugates and Their Uses
|
US20130315913A1
(en)
|
2012-03-26 |
2013-11-28 |
Sanofi |
Anti-light antibody therapy for inflammatory bowel disease
|
JOP20200144A1
(ar)
|
2012-04-30 |
2017-06-16 |
Tillotts Pharma Ag |
تركيبة عقار ذو إطلاق متأخر
|
WO2013188693A1
(en)
|
2012-06-15 |
2013-12-19 |
Imaginab, Inc. |
Antigen binding constructs to cd3
|
CN105051065A
(zh)
|
2012-06-22 |
2015-11-11 |
索伦托治疗有限公司 |
与ccr2结合的抗原结合蛋白
|
US20150224190A1
(en)
|
2012-07-06 |
2015-08-13 |
Mohamed Bentires-Alj |
Combination of a phosphoinositide 3-kinase inhibitor and an inhibitor of the IL-8/CXCR interaction
|
US20150218280A1
(en)
|
2012-08-10 |
2015-08-06 |
University Of Southern California |
CD20 scFv-ELPs METHODS AND THERAPEUTICS
|
WO2014028902A1
(en)
|
2012-08-16 |
2014-02-20 |
Rock West Solutions, Inc. |
System and methods for locating a radiofrequency transceiver in the human body
|
FR2994848B1
(fr)
*
|
2012-08-30 |
2014-08-22 |
Univ Paris Curie |
Traitement de l'arthrose par les hormones incretines ou leurs analogues
|
KR102158467B1
(ko)
|
2012-09-07 |
2020-09-25 |
제넨테크, 인크. |
Ii형 항-cd20 항체와 선택적 bcl-2 억제제와의 병용 치료요법
|
KR101452865B1
(ko)
|
2012-09-17 |
2014-10-21 |
서울대학교산학협력단 |
신규한 ip-10 에피토프 및 이에 대한 항체
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
WO2014055415A1
(en)
|
2012-10-01 |
2014-04-10 |
Mayo Foundation For Medical Education And Research |
Cancer treatments
|
US8865723B2
(en)
|
2012-10-25 |
2014-10-21 |
Tetra Discovery Partners Llc |
Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury
|
US20150232558A1
(en)
|
2012-10-30 |
2015-08-20 |
Emory University |
Stimulating bone formation by inhibition of cd28 co-stimulation
|
US9694071B2
(en)
|
2012-11-02 |
2017-07-04 |
Tg Therapeutics, Inc. |
Combination of anti-CD20 antibody and PI3 kinase selective inhibitor
|
DE102012025143A1
(de)
|
2012-11-07 |
2014-05-08 |
Heraeus Medical Gmbh |
Verfahren zur Wirkstofffreisetzung und Wirkstofffreisetzungssysteme
|
EA035391B1
(ru)
|
2012-11-08 |
2020-06-05 |
Ризен Фармасьютикалз Са |
Фармацевтические композиции, содержащие ингибитор pde4 и ингибитор pi3-дельта или двойной ингибитор pi3-дельта-гамма киназы
|
US8915863B2
(en)
|
2012-11-16 |
2014-12-23 |
L. Zane Shuck |
In vivo device and method for researching GI tract processes, microbes, and variables associated with illnesses and diseases
|
US8491495B1
(en)
|
2012-11-16 |
2013-07-23 |
L. Zane Shuck |
Human intestinal tract research and diagnostic system to evaluate patients and advance medical science and bioengineering and to determine processes in the gut and causes of diseases
|
WO2014078502A1
(en)
|
2012-11-16 |
2014-05-22 |
Novartis Ag |
Use of il-1 beta binding antibodies for treating peripheral arterial disease
|
US8926526B2
(en)
|
2012-11-30 |
2015-01-06 |
L. Zane Shuck |
Patient in vivo gut diagnostic and treatment tool
|
EP2931750B8
(en)
|
2012-12-17 |
2021-11-03 |
Cell Medica Inc. |
Antibodies against il-1 beta
|
WO2014122660A1
(en)
|
2013-02-11 |
2014-08-14 |
Mor Research Applications Ltd. |
Cd14 inhibitors as an effective treatment for hcv infection
|
MX2015012808A
(es)
|
2013-03-12 |
2016-05-31 |
Molecular Templates Inc |
Inmunotoxinas de union a cd20 para inducir internalizacion celular y metodos que usan las mismas.
|
WO2014153181A1
(en)
|
2013-03-14 |
2014-09-25 |
Spot On Sciences, Inc. |
Biological sample collection and preservation
|
US9290570B2
(en)
|
2013-03-15 |
2016-03-22 |
Eli Lilly And Company |
Pan-ELR+ CXC Chemokine Antibodies
|
CN105377892A
(zh)
|
2013-03-15 |
2016-03-02 |
艾伯维生物技术有限公司 |
抗cd25抗体及其用途
|
GB201304738D0
(en)
|
2013-03-15 |
2013-05-01 |
Mars Inc |
Sampling Device
|
WO2014144935A2
(en)
|
2013-03-15 |
2014-09-18 |
Abbvie Biotherapeutics Inc. |
Anti-cd25 antibodies and their uses
|
CA2909230C
(en)
|
2013-04-12 |
2021-06-15 |
Kyoto University |
Method for inducing alveolar epithelial progenitor cells
|
WO2014170317A1
(en)
|
2013-04-17 |
2014-10-23 |
Morphosys Ag |
Antibodies targeting specifically human cxcr2
|
TWI679019B
(zh)
|
2013-04-29 |
2019-12-11 |
法商賽諾菲公司 |
抗il-4/抗il-13之雙特異性抗體調配物
|
PL2992015T3
(pl)
|
2013-05-02 |
2019-01-31 |
F.Hoffmann-La Roche Ag |
Leczenie skojarzone niefukozylowanym przeciwciałem anty-CD20 z koniugatem przeciwciało anty-CD22-lek
|
AR096183A1
(es)
|
2013-05-02 |
2015-12-16 |
Hoffmann La Roche |
Terapia de combinación de un anticuerpo para cd20 afucosilado con un conjugado de anticuerpo para cd79b-fármaco
|
KR20160021125A
(ko)
|
2013-05-17 |
2016-02-24 |
쌩뜨레 나티오날 데 라 르세르쉬 생띠끄 (씨. 엔. 알. 에스) |
항-cxcl1, cxcl7 및 cxcl8 항체 및 이들의 용도
|
US20140349944A1
(en)
|
2013-05-23 |
2014-11-27 |
Musc Foundation For Research Development |
Chaperone-based integrin inhibitors for the treatment of cancer and inflammatory diseases
|
MX371412B
(es)
|
2013-05-23 |
2020-01-29 |
Shire Human Genetic Therapies |
ANTICUERPOS BIESPECÍFICOS QUE SE UNEN ESPECÍFICAMENTE A LOXL2 Y ccl.2, COMPOSICIONES DE LOS MISMOS, Y SU USO EN EL TRATAMIENTO DE ESCLERODERMIA.
|
JP6377153B2
(ja)
|
2013-06-25 |
2018-08-22 |
デジタルダイレクト・アイアール、インク |
サイドスキャン赤外線撮像装置
|
CN113248615A
(zh)
|
2013-07-05 |
2021-08-13 |
根马布股份公司 |
人源化或嵌合cd3抗体
|
US10046002B2
(en)
|
2013-08-02 |
2018-08-14 |
Syntrix Biosystems Inc. |
Method for treating cancer using chemokine antagonists
|
US9324145B1
(en)
|
2013-08-08 |
2016-04-26 |
Given Imaging Ltd. |
System and method for detection of transitions in an image stream of the gastrointestinal tract
|
TW201540301A
(zh)
|
2013-08-16 |
2015-11-01 |
Takeda Gmbh |
以pde4抑制劑治療認知損傷
|
PL226431B1
(pl)
|
2013-08-23 |
2017-07-31 |
Inst Biochemii I Biofizyki Polskiej Akademii Nauk |
Cząsteczka miRNA do zastosowania do wytwarzania leku do zmniejszania reakcji zapalnej lub zapobiegania zwiększaniu się reakcji zapalnej organizmu
|
ES2808682T3
(es)
|
2013-09-26 |
2021-03-01 |
Progenity Inc |
Cápsula de administración con liberación umbral
|
AU2014324608B2
(en)
|
2013-09-27 |
2019-08-08 |
Justin SHER |
Nutraceutical compositon for PDE4 inhibition, enhanced dopamine metabolism and long term potentiation
|
ITMI20131658A1
(it)
|
2013-10-08 |
2015-04-09 |
Getters Spa |
Combinazione di materiali per dispositivi di rilascio di mercurio e dispositivi contenenti detta combinazione di materiali
|
NZ718792A
(en)
|
2013-11-07 |
2020-05-29 |
Hoffmann La Roche |
Combination therapy of an anti cd20 antibody with a btk inhibitor
|
SG10201810298VA
(en)
|
2013-11-13 |
2018-12-28 |
Pfizer |
Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereof
|
DK3736292T3
(da)
|
2013-12-17 |
2024-07-22 |
Genentech Inc |
Anti-CD3-antistoffer og fremgangsmåder til anvendelse
|
US20160249793A1
(en)
|
2013-12-27 |
2016-09-01 |
Kang-Huai Wang |
Capsule Camera Device with Multi-Spectral Light Sources
|
WO2015108785A1
(en)
|
2014-01-15 |
2015-07-23 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
CA2939464A1
(en)
|
2014-02-18 |
2015-08-27 |
Cytodyn Inc. |
Use of anti-ccr5 antibodies in graft versus host disease
|
EP3114139B1
(en)
|
2014-03-04 |
2022-06-15 |
Chemomab Ltd. |
Anti eotaxin-2 antibodies that recognize additional ccr3-binding chemokines
|
US11142584B2
(en)
|
2014-03-11 |
2021-10-12 |
Molecular Templates, Inc. |
CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
|
WO2015140591A1
(en)
|
2014-03-21 |
2015-09-24 |
Nordlandssykehuset Hf |
Anti-cd14 antibodies and uses thereof
|
EP3124005B1
(en)
|
2014-03-28 |
2019-12-11 |
Terumo Kabushiki Kaisha |
Packaged drug-filled container
|
DE102014004843A1
(de)
|
2014-04-02 |
2015-10-08 |
Schaltbau Gmbh |
Gleichstromschütz mit zusätzlicher Schalttauglichkeit für Wechselstromlasten und Polung entgegen der Vorzugsstromrichtung
|
WO2015175773A1
(en)
|
2014-05-15 |
2015-11-19 |
Celgene Corporation |
Use of pde4 inhibitors and combinations thereof for the treatment of cystic fibrosis
|
CA2950415A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Anti-cd20 glycoantibodies and uses thereof
|
CR20160557A
(es)
|
2014-05-29 |
2017-01-20 |
Glaxosmithkline Ip Dev Ltd |
Compuestos derivados de 1-(ciclopent-2-en-1-il)-3-(2-hidroxi-3-(arilsulfonil)fenil)urea como inhibidores cxcr2
|
BR112016028957B1
(pt)
*
|
2014-06-11 |
2021-12-14 |
The Brigham And Women's Hospital, Inc. |
Estrutura de residência gástrica
|
FR3022142B1
(fr)
|
2014-06-16 |
2019-07-12 |
Universite Paul Sabatier - Toulouse Iii |
Inhibition de la chimiokine ccl7 ou de son recepteur ccr3 pour le traitement et le diagnostic du cancer de la prostate
|
CN107108738A
(zh)
|
2014-07-25 |
2017-08-29 |
西托姆克斯治疗公司 |
抗cd3抗体、可活化抗cd3抗体、多特异性抗cd3抗体、多特异性可活化抗cd3抗体及其使用方法
|
AU2015295507A1
(en)
|
2014-07-31 |
2017-02-02 |
Glaxosmithkline Intellectual Property Development Limited |
Use of CXCR2 antagonists for the prevention and/or treatment of chemotherapy induced peripheral neuropathy (cipn)
|
US20160066855A1
(en)
|
2014-09-05 |
2016-03-10 |
Elwha LLC, a limited liability company of the State of Delaware |
Systems, methods, and devices addressing the gastro-intestinal tract
|
KR102397233B1
(ko)
|
2014-09-25 |
2022-05-12 |
프로제너티, 인크. |
위치추정 능력을 갖는 전기기계 알약 장치
|
US10729895B2
(en)
*
|
2014-09-30 |
2020-08-04 |
The Regents Of The University Of California |
Active agent delivery devices and methods of using the same
|
BR112017006520A2
(pt)
|
2014-09-30 |
2017-12-19 |
Bristol Myers Squibb Co |
métodos de tratamento do lúpus eritematoso sistêmico usando um anticorpo de domínio direcionado contra cd28
|
US10300259B2
(en)
*
|
2014-10-22 |
2019-05-28 |
Purdue Research Foundation |
Smart capsule with GI-tract-location-specific payload release
|
US10064544B2
(en)
|
2015-01-26 |
2018-09-04 |
The Chinese University Of Hong Kong |
Endoscopic capsule and endoscopic system
|
US20160272702A1
(en)
|
2015-03-18 |
2016-09-22 |
University Of South Carolina |
Anti-ccl8 therapy for breast cancer
|
IL254577B2
(en)
|
2015-03-31 |
2023-11-01 |
Vhsquared Ltd |
polypeptides
|
DK3280729T3
(da)
|
2015-04-08 |
2022-07-25 |
Novartis Ag |
Cd20-behandlinger, cd22-behandlinger og kombinationsbehandlinger med en cd19-kimær antigenreceptor (car)-udtrykkende celle
|
RS59204B1
(sr)
|
2015-05-26 |
2019-10-31 |
Hoffmann La Roche |
Kombinovana terapija anti-cd20 antitelom sa inhibitorom bcl-2 i inhibitorom mdm2
|
CN107683107B
(zh)
|
2015-06-02 |
2021-06-04 |
基文影像公司 |
用于体内免疫测定的装置、系统和方法
|
JP6731958B2
(ja)
|
2015-06-12 |
2020-07-29 |
ノヴォ ノルディスク アー/エス |
選択的pyy化合物及びその使用
|
EP3108810A1
(en)
|
2015-06-23 |
2016-12-28 |
Valtronic Technologies (Holding) SA |
Ingestible device for measuring glucose concentration
|
JP2017012395A
(ja)
|
2015-06-30 |
2017-01-19 |
富士フイルム株式会社 |
内視鏡システム及び内視鏡システムの作動方法
|
EP3316873B1
(en)
|
2015-06-30 |
2021-04-28 |
Entrega Inc. |
Device for oral delivery of active agents
|
CA2991880A1
(en)
|
2015-07-10 |
2017-01-19 |
Merus N.V. |
Human cd3 binding antibody
|
TWI724056B
(zh)
|
2015-11-19 |
2021-04-11 |
美商卡默森屈有限公司 |
Cxcr2抑制劑
|
CN108602885B
(zh)
|
2015-11-30 |
2022-05-24 |
百时美施贵宝公司 |
抗人ip-10抗体及其用途
|
US10610351B2
(en)
|
2016-03-08 |
2020-04-07 |
Picocyl |
Gas canisters and methods for making them
|
ES2843974T3
(es)
|
2016-03-17 |
2021-07-21 |
Tillotts Pharma Ag |
Anticuerpos anti-TNF alfa y fragmentos funcionales de los mismos
|
JP7224917B2
(ja)
|
2016-03-31 |
2023-02-20 |
ソリッソ ファーマシューティカルズ,インク. |
組成物
|
AU2017277524B2
(en)
|
2016-06-07 |
2021-07-29 |
Dermavant Sciences GmbH |
Topical formulations of PDE-4 inhibitors and their methods of use
|
JP7153633B2
(ja)
|
2016-08-18 |
2022-10-14 |
ビオラ・セラピューティクス・インコーポレイテッド |
サンプリングシステム、ならびに関連する材料および方法
|
JP2019526423A
(ja)
*
|
2016-09-09 |
2019-09-19 |
ミッチェル・ローレンス・ジョーンズMitchell Lawrence JONES |
分注可能物質の送達のための電気機械的摂取可能装置
|
CA3035125A1
(en)
|
2016-09-15 |
2018-03-22 |
Progenity, Inc. |
Fluid sampling device
|
WO2018111326A1
(en)
*
|
2016-12-14 |
2018-06-21 |
Progenity Inc. |
Methods and ingestible devices for the regio-specific release of immunosuppressants at the site of gastrointestinal tract disease
|
CN106725634B
(zh)
*
|
2017-01-23 |
2024-01-16 |
天津医科大学总医院 |
肠道微生物采集胶囊
|
CA3054159A1
(en)
*
|
2017-03-30 |
2018-10-04 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a chst15 inhibitor
|
JP7071995B2
(ja)
|
2017-03-31 |
2022-05-19 |
プロジェニティ, インコーポレイテッド |
摂取可能装置
|
JP7038739B2
(ja)
|
2017-05-17 |
2022-03-18 |
マサチューセッツ インスティテュート オブ テクノロジー |
自己復元物品
|
US11541015B2
(en)
*
|
2017-05-17 |
2023-01-03 |
Massachusetts Institute Of Technology |
Self-righting systems, methods, and related components
|
WO2019178071A1
(en)
|
2018-03-13 |
2019-09-19 |
Progenity, Inc. |
Ingestible device with relatively large payload volume
|
TWI705820B
(zh)
*
|
2018-06-22 |
2020-10-01 |
美商美國禮來大藥廠 |
Gip/glp1促效劑組合物
|
US20210213263A1
(en)
|
2018-08-23 |
2021-07-15 |
Baywind Bioventures |
Capsule device for delivery of active agent to gastrointestinal tract
|
KR20210095165A
(ko)
|
2018-11-19 |
2021-07-30 |
프로제너티, 인크. |
바이오의약품으로 질환을 치료하기 위한 방법 및 디바이스
|
WO2020157324A1
(en)
|
2019-02-01 |
2020-08-06 |
Novo Nordisk A/S |
Medical device with actuation mechanism
|
US11771829B2
(en)
|
2019-02-01 |
2023-10-03 |
Massachusetts Institute Of Technology |
Systems and methods for liquid injection
|